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ABSTRACT

Author: Deo, Ridhi. M.S.
Institution: Purdue University
Degree Received: August 2018
Title: Detection and Management of Diabetes Mellitus (Type -II)
Major Professor: Suranjan Panigrahi
Diabetes is a life threatening disease. Diabetes is also hereditary and its incidence
depends on factors pertaining to the health, lifestyle and family background of an
individual. Gestational Diabetes Mellitus (GDM) is a special case in diabetes which
occurs only during pregnancy. The aim of the author’s thesis is to mathematically model
the risk factors for diabetes (type - 2). The factors are modeled to predict if an individual
will have diabetes. The model is aimed at being benefcial to patients so that they can
determine if their current lifestyle habits are healthy. The purpose of the thesis is to
explore potential pathways and provide a proof of concept for detecting glucose
non-invasively using saliva.
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CHAPTER 1. INTRODUCTION
Diabetes has taken its toll on people of all age groups. Diabetes is harmful not
only in the forms of diabetes type I and II but also in the form of gestational diabetes.
Diabetes type I is a form of auto-immune disease. Diabetes type II is a condition caused
due to insulin resistance presented by the body and is the most common form of diabetes.
Gestational diabetes is a condition similar to type II diabetes. GDM is diagnosed during
weeks 24- 28 of pregnancy and is harmful for both the mother and the baby during and
after pregnancy.
When a person is diagnosed with diabetes type-2, the popular way currently to
monitor it regularly is using devices that take a blood sample and give out the blood sugar
content reading. The same is the case for women diagnosed with Gestational Diabetes
Mellitus (GDM). The risk of infections and blood loss is higher with invasive forms of
detection. Non-invasively detecting diabetes will therefore be useful.
Gestational diabetes has several proven risk factors (Ben-Haroush, Yogev, & Hod,
2004a; Bryson, Ioannou, Rulyak, & Critchlow, 2003; Hedderson, Gunderson, & Ferrara,
2010; Solomon et al., 1997). Predicting the combined risk of these factors can lead to
meaningful information that can be used to make people aware of the risk factors.
Awareness of the risks associated with lifestyle habits will help in reducing the incidence
of diabetes.
Once a patient is diagnosed with gestational diabetes, there is no exact procedure
to follow to keep it in check. There are regular doctor appointments to follow up but in
most developing countries, pregnant women tend to miss these appointments. The aim of
this thesis is to address the gap in managing diabetes systematically. The frst objective of
this thesis is to model the different factors associated with diabetes and determine the
incidence of diabetes. Information from the model can be used by patients, doctors and
health care technologists to develop a systematic routine for better management of GDM.
For the detection of diabetes, potential pathways that are non-invasive and low cost are
presented in the thesis.
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1.1 Scope
The most popular method to diagnose and manage diabetes is by performing a
blood sugar test, before and after fasting. Once a patient is diagnosed with diabetes, they
need to keep it in check every day by testing the blood sugar using the fnger pricking
method. The lancet method is both painful and risk inficting, especially for pregnant
women. Pricking causes loss of blood on a daily basis and is not a pleasant experience. A
dire need for a non-invasive, easy to use, and accurate method for diabetes detection is
essential. The aim of this research was to explore potential pathways of non-invasive
blood sugar detection. Two potential samples instead of serum are human breath and
human saliva.
To address the issue with ’managing’ blood glucose levels, a statistical model of
the parameters is designed. The intent is to predict how risky the combination of certain
factors like age, weight and family history of diabetes are. The idea is to use mathematical
modeling to create a model and then use the model to predict diabetes with new patient
information. The results obtained from the model can be used by individuals and will be
helpful to make changes in general lifestyle habits.

1.2 Signifcance
According to a WHO report from 2016, 422 million adults were living with
diabetes in 2014. The global prevalence of diabetes among adults over 18 years of age has
risen from 4.7% in 1980 to 8.5% in 2014. Over the past decade, diabetes prevalence has
risen faster in low- and middle-income countries than in high-income countries. 1.5
million deaths were caused due to diabetes in 2012. An additional 2.2 million deaths were
caused by higher-than-optimal blood glucose, increasing the risks of cardiovascular and
other diseases. 43% of these 3.7 million deaths occur before the age of 70 years. The
percentage of deaths attributable to high blood glucose or diabetes that occurs prior to age
70 is higher in low- and middle-income countries than in high-income countries (Global
Report on Diabetes, 2016).
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Among pregnant women, 2% to 17.8% develop gestational diabetes (Negrato,
Mattar, & Gomes, 2012). Women who have had gestational diabetes have a seven fold risk
of developing diabetes type-2 as compared to other women (Bellamy, Casas, Hingorani, &
Williams, 2009). The incidence of GDM is increasing each year. When women get
diagnosed with GDM, they are asked to monitor their blood glucose everyday.
The process of self-monitoring can get expensive for all forms of diabetes (type I,
II and, GDM) as the device uses disposable strips. Self-monitoring needs people to be
aware of the specifcs to use the device. Self-monitoring devices give incorrect readings if
not used as per the exact instructions on the device manual. For instance, glucometers
need people to have clean fngers before pricking and recommend use of alcohol pads
before drawing a sample. The depth of the lancet is another tricky aspect. If the depth is
set to be too deep, it can cause a lot of pain. On the other hand, if the depth is too low, it
won’t draw enough blood. The need for a cost effective, pain free and easy to use method
is highlighted.

1.3 Objective

• To develop a computational model for predicting the individual risk of diabetes.
• To explore pathways for diabetes detection using saliva in the complete salivary
glucose range.

4

CHAPTER 2. REVIEW OF LITERATURE
Chapter two is a collection of the recent literature review in the areas of
epidemiology of diabetes and gestational diabetes, disease data modeling and
non-invasive diabetes detection. The frst two sections in this chapter explain the increased
incidence and impact of diabetes and gestational diabetes on human health.

2.1 Epidemiology of Diabetes type 2
The pathophysiology of diabetes type 2 can be explained as a condition in which
the body develops an unusual increase in insulin resistance. In the case of diabetes type II,
the person’s body may be producing enough insulin but the body is unable use it as it
poses resistance to the produced insulin.
Lifestyle changes, increased portion sizes for food intake and genetic
susceptibility have increased the incidence of diabetes type 2 all over the world (Winer &
Sowers, 2004). Pancreatic β cells are a type of cell found in the islets of pancreas. Their
purpose is to store and release insulin. Common variants in genes infuencing pancreatic β
- cell function may make a signifcant contribution to the inherited component of diabetes,
confrming that genes play a major role in chances of getting diabetes (Barroso et al.,
2003). However, the increased diabetes incidence disproportionately impacts individuals
based on certain factors. Factors like smoking, age, ethnicity and hereditary factors affect
the chances of getting diabetes. Physical activity and smoking are well-recognized risk
factors for developing type 2 diabetes as well (Group, 2002).
”Type-2 diabetes is the leading cause of premature deaths” (Asif, 2014). Diabetes
type 2 is also hereditary which is one of the major reasons why it is crucial to diagnose it
early and manage it continuously. About 90 - 95% of diabetes burden in the USA is due to
diabetes type-2 (Deshpande, Harris-Hayes, & Schootman, 2008).
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2.2 Epidemiology of Gestational Diabetes
There are 1,801,138,875 women in the age group of 18 - 50 years old in the world,
which is the potential child bearing population (Bureau & Staff, 2017). Every pregnant
woman has the risk of diabetes occurring during her pregnancy.However the risk is higher
if they are obese, older than 25 years, have a previous history of abnormal glucose
metabolism or poor obstetric outcome, have frst-degree relatives with diabetes, or are
members of ethnic groups with high prevalence of diabetes (Jovanovic & Pettitt, 2001).
Similar to type-2 diabetes, GDM is also infuenced by several factors, for instance, a
person’s lifestyle and family history of gestational diabetes (Kim et al., 2007).
Maternal health and fetal metabolism are two crucial aspects of a pregnancy and
gestational diabetes infuences them both. In some cases of normal pregnancy, insulin
resistance of the woman’s body increases and the pancreatic β -cell reserve is over-worked
to maintain the glucose levels within normal range (Xiang et al., 1999). β - cells fail to
maintain the glucose in normal range and the body experiences excess glucose in the
blood, which is termed as gestational diabetes.
Gestational diabetes not only complicates the pregnancy and infuences the fetal
metabolism, but also leaves severe after effects. A condition called ’Fetal Macrosomia’, in
which the birth weight of the baby is greater than the 90th percentile for gestational age
and sex or two standard deviations above the normal mean weight, may affect up to 40%
of the babies, where gestational diabetes affected pregnancies (de Veciana et al., 1995).
The risk of shoulder dystocia is increased by around 30 times in diabetic pregnancies
when the infants weigh more than 4500 g (Gonen, Bader, & Ajami, 2000). ”When the
obstetrician delivers the infant early to stop the accelerated in - utero growth,
complications related to prematurity, such as hyperbilirubinemia, hypocalcemia, and
respiratory distress, may result” (Chatfeld, 2001). The infant of a woman with GDM is at
higher risk of developing obesity, impaired glucose tolerance (IGT), or diabetes at an early
age (Pettitt, Baird, Aleck, Bennett, & Knowler, 1983).
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Each year, almost 210 million women become pregnant but only 130 million give
birth. An estimated 15% of the women develop complications and approximately one
third of those are life threatening. As a result, more than half a million women, most of
them who live in developing countries, will die (O’Heir, 2004). GDM is one of the major
life threatening complications. When detected early, GDM can be monitored over a period
to ensure a healthy life for the baby and the mother.
More about the epidemiology of GDM and its association with type 2 diabetes is
summarized by Ben-Haroush, Yogev, and Hod (2004b). Based on their research, it has
been established that ethnicity is an independent risk factor for GDM and that its
prevalence varies based on the prevalence of type II diabetes in the given ethnic group.
”Importantly, women with an early diagnosis of GDM, in the frst half of pregnancy,
represent a high-risk subgroup, with an increased incidence of obstetric complications,
recurrent GDM in subsequent pregnancies, and future development of Type 2 diabetes.
Other factors that place women with GDM at increased risk of type 2 diabetes are obesity
and need for insulin for glycemic control. Furthermore, hypertensive disorders in
pregnancy and afterwards may be more prevalent in women with GDM” (Ben-Haroush et
al., 2004b). The conclusion was that the epidemiological data suggested an association
between several high-risk pre-diabetes states, GDM, and type 2 diabetes.
Researchers and doctors are still not aware of the exact reasons as to why GDM
occurs in certain women only. However, the incidence of GDM is steadily increasing
every year. Previous research shows that there are certain factors, which increase the
¨
chances of a woman to be diagnosed with GDM (Caliskan, Kayikcioglu, Oztürk,
Koc, &
Haberal, 2004; Naylor, Sermer, Chen, & Farine, 1997; Teh et al., 2011). Researchers have
tried to model these risk factors to answer questions like − the need to reduce GDM
screening tests on women with low risk for diabetes.
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Women who have had gestational diabetes are advised to have their glucose
tolerance assessed six weeks after delivery (Gavin et al., 1997). Low rates of attendance
for this follow up suggest that health-care professionals and/or women with GDM, do not
understand the importance of this disorder and the risk of developing type 2 diabetes later
in life. The chance to prevent the occurrence of diabetes is therefore missed (Kim, 2007) .
Moreover, no specifc procedure exists for managing and monitoring gestational diabetes.
There are different ways of diagnosing gestational diabetes. GDM is diagnosed
through prenatal screening instead of waiting for the symptoms to show up. The most
popular method is taking a glucose tolerance test (GTT), before and after fasting. Based
on standardized test values, it determines if a pregnant woman is diabetic or not. If the
patient turns out to be diabetic, they need to manage and monitor it on a regular basis.
Daily self monitoring of blood glucose (SMBG) poses a hurdle to individuals in
developing countries. Research shows that - ”Daily SMBG is feasible in high income
settings, but not necessarily in low-income settings where glucose meters and testing
strips are costly. SMBG also requires women to be able to read and write, which is a
challenge in many sub-Saharan African and South Asian countries with high rates of
female illiteracy” (Utz, Kolsteren, & De Brouwere, 2015).Keeping the cost factor of
regular glucose monitoring in mind, the aim of the thesis is to explore low cost
alternatives to blood glucose detection by replacing blood with saliva.

2.3 Review of data modeling for diabetes disease domain
Statistical and mathematical techniques have been previously used to develop
computational models for disease management. Lamain de Ruiter et al. (2017) published
a systematic review of the prediction models developed for GDM. Three of these models
have sensitivity and specifcity above 65 and the models were extensively reviewed to
gather relevant information(Caliskan et al., 2004; Naylor et al., 1997; Teh et al., 2011).
The summary of previous models is shown in tables 2.1, 2.2.
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Caliskan et al. (2004) aimed at reducing the screening tests for GDM. It was found
that maternal age, body mass index, prior adverse obstetric outcome, family history of
diabetes and prior macrosomic fetus were statistically signifcant risk factors (p<0.05).
The patient selection was done from a teaching hospital. 422 pregnant women, with
singleton pregnancies in their 24th-28th week of gestation were invited. The mean age of
the women included in the study was 24.9 ± 4.9. A 50 g glucose tolerance test was
performed and the results were recorded. Logistic regression analysis through SPSS
(version 11.0) was used. The Forward Wald method was used and it was discovered that
prior intra uterine growth restriction, pre-eclampsia, chronic hyper tension, multiparity
and newborns with low birth weight were not signifcant factors. Sensitivity, specifcity,
positive and negative predictive values were used at the 95% confdence interval (Caliskan
et al., 2004) for the glucose tolerance test.
Another study to devise new screening strategies for GDM by Naylor et al. (1997),
used a bigger sample size of 3131 pregnant women. The SAS software was used to
develop a simple scoring system using multivariate logistic regression. Age, race and
body mass index were used as the clinical factors based on which the scoring system was
developed. Family history of diabetes and adverse obstetrical history were not used as
clinical factors as they had lower signifcance (p =0.15 and p=0.13 respectively).
According to a study conducted based on data collected from a hospital in
Australia (Teh et al., 2011), history of GDM, increased maternal age (>= 40) and BMI
(>= 35) were identifed as the strongest independent risk factors for GDM in a developed
country.
Of all the models reviewed, risk factors were considered either as a part of
univariate analysis or multivariate analysis. Logistic regression or multivariate regression
were the most commonly used statistical approaches. The combined effects of the factors
was not used for prediction. For this research, an attempt was made to use machine
learning based algorithms to predict the individual risk of diabetes. The methods used and
results obtained are presented in the sections 3.1 and 4.1 respectively.
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2.4 Review of non-invasive diabetes detection methods
Two non-invasive diabetes detection methods were researched. The frst method is
breath based diabetes detection and the second method is saliva based diabetes detection.
The literature used regarding the above mentioned methods are outlined below.

2.4.1 Human Breath based diabetes detection
Breath is composed of a highly complex molecular matrix, containing both
abundant chemical mixtures along with trace constituents. It contains nitrogen, oxygen,
carbon dioxide and water vapor. Breath also has trace constituents, which include the
different volatile organic compounds (VOCs). There are as many as 1000 different
components in the mixture. These VOCs are present at extremely low concentration,
which makes it highly diffcult to detect them. Diagnostically, biomarker concentration
levels of indicative markers are estimated to range between parts-per-billion (ppb) to
parts-per-trillion (ppt) concentration levels, which are quite diffcult to identify by the help
of conventional instrumental techniques (Shelat, Patel, & Desai, 2012).
Endogenous molecules in human breath such as acetone, nitric oxide, hydrogen,
ammonia, and carbon monoxide are produced by metabolic processes and partition from
blood via the alveolar pulmonary membrane into the alveolar air (Schubert, Miekisch,
Geiger, & Noldge-Schomburg, 2004). These molecules are present in breath relative to
their types, concentrations, volatilities, lipid solubility, and rates of diffusion as they
circulate in the blood and cross the alveolar membrane (Sehnert, Jiang, Burdick, & Risby,
2002). Therefore, changes in the concentration of these molecules could suggest various
diseases or at least changes in the metabolism.
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For diabetic patients the body does not produce enough insulin (diabetes type-1).
This leads to glucose not entering the bloodstream, thereby the cells in the body are
energy deprived. To produce energy, these cells start burning the fat in the body. One of
the by-products of fat metabolism in the body is ketones. The body produces three
ketones one of which is acetone. When ketones start accumulating in the blood stream,
ketoacidosis occurs. Ketone bodies have a characteristic smell, which can easily be
detected in the breath of persons in ketosis and ketoacidosis.
Analyzing the VOCs in human breath can help us determine if a person has a
specifc disease. Levels of VOCs in normal people and in people with diseases are
different. For example, nitric oxide levels present in exhaled breath could be used for
detection of Asthma and COPD (Heffer et al., 2006). Ammonia is signifcantly high in
patients with renal diseases (Davies, Spanel, & Smith, 1997). The idea here is to detect
acetone, which is an established biomarker for type-1 diabetes in human breath.
Within the literature, a few sensors that can detect the presence of acetone are
available. For instance, an ε - WO3 sensor, that can detect acetone in the range of 0 - 1.8
ppm was proposed (Wang et al., 2010). The sensor has a response time of 20 seconds and
varying sensitivity in different ranges. The sensor works based on resistive sensors and
reacts to methanol and ethanol after 3ppm; both of which are present in breath. The sensor
operates only in the temperature range of 5000 C and requires a micro heater. Using a
micro heater reduces the life of the device. A fowchart representing the working of the
sensor is shown in fgure 2.1.
Another sensor, made from Chitosan material was also reported to detect acetone
in the range of 0-1.8ppm, with a response time of 10 seconds (Nasution et al., 2013). The
advantage of this particular sensor compared to most other sensors is that it works at room
temperature. The sensor is reported to be slightly selective to methanol, but can be
calibrated to overcome the issue. The reported issue with this sensor is that it has a short
life span due to the swelling of the sensor material. A fowchart representing the working
of the sensor is shown in fgure 2.2
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A micro-system based on LTCC (low temperature cofred ceramics) technology
was proposed by Rydosz et al. (2016). The system uses warmed up breath bags to collect
breath samples. The system uses pre-concentration technique in LTCC technology to
adsorb gas and pass it over a gas sensor array, which has eight commercial sensors by
Figaro. The response of the sensor is discrete and it is required to be connected directly to
the computer. The system works well to serve the purpose of detection but fails to act as a
hand-held device and is expensive due to the cost of commercial sensors involved. A
fowchart representing the working of the sensor is shown in fgure 2.3
A nano-technology based TiO2 sensor that operates in the range of 3650 -4300 C
was reported (Wang et al., 2009). The sensor requires a micro-heater. The sensor is cost
effective and works in the ppm range of 1-1.5ppm for detecting acetone. The sensor also
works well in presence of water vapor. The downside is that it can detect only up to
1.5ppm and not all the way up up to 1.8 ppm. The sensor requires heating and therefore
more power. A fowchart representing the working of the sensor is shown in fgure 2.4.
Righettoni et al. developed a sensor specifcally for diabetes detection by Exhaled
Breath Analysis using Si- WO3 that work excellently even in 90% RH conditions
(Righettoni et al., 2010). The sensor works in the range of 3250 - 5000 C. The sensor also
has high sensitivity and a selectivity of 4.7 to 6.7 times towards acetone over ethanol. The
sensor has good cross sensitivity with respect to water vapor. Gas sampling in these
sensors was accomplished by using heated Tefon tubes using an insulated heating wire. A
fowchart representing the working of the sensor is shown in fgure 2.5
Although a variety of breath-based sensors are available, the sensors lack in one or
more of the following categories : low cost, point of care(PoC) device, inability to operate
without heating and long shelf life. Section 3.2.1 explores why breath based detection can
lack specifcity to diabetes.
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2.4.2 Saliva based detection system
Saliva is easy to sample and can be used for non-invasive detection of glucose
based on the literature review presented in this section. Yamaguchi, Mitsumori, and Kano
(1998a) proved the correlation of blood glucose and salivary glucose levels which enabled
researchers to use saliva as an index for diabetes detection. Studies following Yamaguchi
et al. (1998a) have also reported positive correlation between glucose levels in saliva and
in blood, which show that saliva can be used to predict glucose levels in diabetic patients
(Panchbhai, Degwekar, & Bhowte, 2010; Puttaswamy, Puttabudhi, & Raju, 2017).
According to Yamaguchi, Mitsumori, and Kano (1998b), the range of SG is 0.15 mg/dL to
3.82 mg/dL in healthy subjects. Another study found the range of SG to be in 4.30 mg/dL
to 12.90 mg/dL for healthy individuals and 10.00 mg/dL-32.00 mg/dL for individuals with
diabetes (Gupta, Sandhu, Bansal, & Sharma, 2014). Du, Zhang, and Wang (2016) found
the range to be 0.3 mg/dL - 20 mg/dL. Seminal research by Yamaguchi et al. is considered
as the salivary glucose range standard in the research conducted.
Sensors developed by researchers for saliva based detection are critically reviewed
below. A detailed review paper for saliva based glucose detection is put together by
Malon, Sadir, Balakrishnan, and Córcoles (2014).
A non-invasive sensor developed by W. Zhang, Du, and Wang (2015) is reviewed
here . The sensor uses an on- chip disposable nano-sensor. The sensor shows good results
in terms of constant correlation between blood glucose and salivary glucose levels as
verifed using the oral glucose tolerance test (OGTT) (W. Zhang et al., 2015). However,
the research was conducted only on two patients. Saliva collected from two individuals
was split into several different samples for the experiment. The results do not account for
any health conditions that the individuals might have had (like an oral cavity infection,
smoking etc.). There were no diabetic patients involved in the study. The blood glucose
correlation presented is based on the healthy individuals sugar levels before and after
consuming glucose.
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The sampling procedure used by W. Zhang et al. involves rinsing the mouth with
water before collecting saliva. While this process removes some contaminants from the
mouth, it needs to be revalidated to ensure that there was no contamination on the salivary
glands especially after consumption of glucose. The saliva collected from the subjects is a
mixture of saliva from all glands. There is a need to verify the results after collecting
glucose only from the submandibular and sublingual glands. Comparison of a fnger stick
testing method with W. Zhang et al. (2015) sensor response with diabetic patients would
have been useful as it would not involve any consumed glucose interference.
As a continuation of research reported by W. Zhang et al. (2015), another
researcher, Du et al. (2016) developed a disposable nano-biosensor using a layer by layer
assembly process . The research goal was to fnd SG levels in real time, specifcally in the
hyperglycemic conditions. Seven glucose monitoring tests were conducted and it was
found that the correlation between BG and SG is signifcant (r = 0.74, P < .001). One of
the bottlenecks of using saliva as a sample for the sensors, is the viscosity of saliva. It can
be different based on which glands it is obtained from and this can pose a problem by
clogging the top layer of the sensor. To avoid this, Du et al. (2016) used a PVDF
(polyvinylidene fuoride) membrane. Sensors with multilayer flms of carbon nano tubes
were fabricated and packed in gel boxes which were preserved at 40 C when not in use.
The sensors had three electrodes. A working electrode, a reference electrode and a counter
electrode. For the study, 10 volunteers in the age group of 20-60 years were selected. No
diabetic patients were a part of this study. The sensors were tested using the saliva
collected from the participants in the study. A constant voltage of 0.05V was applied to
the sensor for the amperometric tests which was converted to SG values using a formula
derived from a linear regression curve. Final SG values were displayed in mg/dL after
data processing through MATLAB. The sensor can detect down to 0.1mg/dl and can be
used as a point of care device.
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Measuring SG levels several times a day was found to be effective by Du et al..
The different times to measure were found out to be: once upon waking up, before and 2
hours after each meal, and before sleep, to indicate diabetes conditions. Du et al. also
found that fasting SG is a strong indicator for blood glucose unless the subjects health
condition changes (due to a fever, cold or menstrual cycles). The sensor was used to take
the measurements using saliva samples from healthy individuals. For the validation of
their sensor, a quantitative detection of glucose was conducted. To remove the effect from
the acid producing bacteria, the saliva was boiled and residue was removed immediately
before the analysis. Results from Du et al. show that there was a high correlation between
SG values shown by the sensor and the ultra violet measured glucose (R2 = 93.6%). Du et
al. found that the sensor diagnosed linearly in the range of 1.1-10.1 mg/dL. The sensor is
not suited to measure the situations in which blood sugar levels are very low when
compared to the standard range used in the author’s research. But when compared to the
SG range obtained by Du et al. (2016), the device neither detects hypoglycemic nor
hyperglycemic conditions. There is a need to improve the range of the sensor for clinical
diagnosis. As no diabetic patients were included in Du et al.’s research, it is of utmost
importance to ensure that the glucose detected in saliva is not from any glucose residues
but from the saliva produced by the body. Another concern is regarding the sampling
procedure. The protocol proposed by Du et al. (2016) requires users to collect saliva by
placing two cotton balls in their mouth. The cotton balls are then placed in a syringe and
the saliva is compressed out. The protocol could be conducted by clinics and hospitals but
it would be inconvenient to use the sensor in a household setup. An easier method to
sample saliva is essential in order to make the device usable with minimal training.
Performing similar tests by including a diabetes group and a diabetes control group is
recommended to ensure clinical accuracy.
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Paper based detection has also been used to detect glucose in saliva. Paper based
sensing is an inexpensive and quick method to use, which requires minimal training. In
the research conducted by Soni and Jha (2015), an optical biosensor was used for the
direct detection of salivary glucose. Filter paper strips were cut and immobilized with a
pH sensitive dye to detect glucose. The color of the test strip changed when hydrogen
peroxide was generated during the enzymatic reaction between glucose and glucose
oxidase. An offce scanner combined with software to analyze RGB pixels was used to
deduce a biosensor calibration curve.
To ensure a pH balance and to detect the amount of glucose in saliva, a working
solution of glucose oxidase (GOD) was made and pH balanced dye was added to it. The
solution was thoroughly mixed and the solution was poured over it. The strips were
immobilized with GOD using the adsorption method. An average RGB histogram was
obtained after scanning and pixelating the image. The dispersion of the enzyme solution
was not homogeneous on all strips since it was done manually. Amongst R,G and B, blue
showed the highest sensitivity(0.0033 pixel/mg dL− 1) to glucose. It was discovered that
pH levels of the strips remain stabilized for up to 60 days when stored at 40 C, thereby
giving the test strips a shelf life of 60 days. The paper based method is inexpensive and
can be used to screen mass populations for diabetes. But, the sensor has a limit of
detection(LOD) of 22 mg/dL. The paper based sensor cannot be used to measure low
levels of glucose in saliva like 0.15mg/dL, which is required when the patient hits low
blood sugar levels. Paper based diagnosis is low cost and can be incorporated into a
portable device by using the camera of a cell phone instead of an offce scanner.
A similar approach was also used by Santana-Jim´enez, M´arquez-Lucero, Osuna,
Estrada-Moreno, and Dominguez (2018). They used two enzymes - GOD and horse radish
peroxidase. The use of a bi-enzymatic approach brought Santana-Jiménez et al.’s limit of
detection down to 0.84 mg/dl with synthetic saliva. However it still does not span the
complete salivary glucose range.
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Another approach indirectly detected glucose in saliva using a proteomic approach
(Rao et al., 2009). The proteomic method assess the glucose level based on the change in
the proteins in saliva. The proteomic approach indirectly quantifes glucose in saliva. The
approach is very different compared to the other direct glucose detection methods
reviewed in the research. The proteomic approach is considered beyond the scope of this
thesis.
Selected research conducted in the feld of salivary glucose detection was critically
reviewed. Potential pathways for low-cost, full-range salivary glucose detection were
explored. The methods adopted and the results obtained are outlined in chapters 3 and 4
respectively.

2.5 Summary
Chapter 2 provided a review of the literature relevant to the data modeling in the
diabetes disease domain and sensors for breath and saliva based glucose detection. The
next chapter provides the methodology used in the research.

Figure 2.1. Flowchart representing the working of ε - WO3 sensor (Wang et al., 2010).
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Figure 2.2. Flowchart representing the working of Chitosan sensor (Nasution et al., 2013).

Figure 2.3. Flowchart representing the working of LTCC based sensor (Rydosz et al.,
2016).

Figure 2.4. Flowchart representing the working of TiO2 sensor (Wang et al., 2009).
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Figure 2.5. Flowchart representing the working of sensor by Righettoni et al. (2010)
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CHAPTER 3. RESEARCH METHODOLOGY
Chapter three will cover the research framework used. It highlights the
methodology used for modeling the data. Adding to this, breath and saliva are critically
reviewed as samples for glucose detection. In detail protocols of the experiments
conducted in lab for salivary glucose detection are outlined.

3.1 Objective 1- To develop a computational model for Diabetes management
To manage diabetes or pre-diabetes conditions systematically a prediction model
based on risk factors is developed. Sections below outline the methodology used.

3.1.1 Data acquisition
Patient data was required to develop the computational model for diabetes. After
an extensive search, data provided by the Center for Disease Control and Prevention
(CDC) was used. Another way to obtain data was by conducting various surveys and
collecting the data ourselves. But, the process of data acquisition from human subjects
requires a lot of time and is bound by appropriate approval procedures. In view of the time
line, a decision was made that using data from a public dataset would be a feasible option.
The acquired data was reported to Purdue IRB and an exempt request was fled. IRB
approved the exempt request (PROPEL 57629806, IRB Protocol 1806020710.
Confrmation email attached in appendix).
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3.1.2 Data processing in SAS®9.4 software
The Continuous NHANES (National health and nutrition exam survey) data was
used from the CDC’s website Continuous NHANES (2011-2014) - Data Files (2018). All
results and conclusions drawn from this data are based upon how the original data was
gathered by CDC. The data provider collected data in the forms of questionnaires, lab
tests and, medical examinations. Continuous NHANES data was divided into six
categories. The categories were: Demographics, Dietary, Examination, Laboratory,
Questionnaire and Limited Access. The limited access fles needed a different protocol to
enable access and were not used in the research. The other fve categories (mentioned
above, barring the limited access category) were used to create the mathematical model.
The number of variables provided by CDC in the Continuous NHANES dataset were
more than 3000. For the purpose of creating a model, all the variables in the data were
examined and after careful consideration, the relevant variables based on research interests
were determined. A keyword search was conducted and the variables of interest were
kept. The remaining variables were discarded. Figure 3.1 below represents how the data
processing was conducted.

25
3.1.3 Data preprocessing in MATLAB®
All the data samples were provided with unique sequential numbers for data
identifcation. The variables used as predictor variables were age, ethnicity, gender, BMI,
blood pressure, lab cholesterol, nutrition intake, calorie consumption, ftness, smoking and
drinking habits. The output variable used was the glucose value from an Oral Glucose
Tolerance Test (OGTT). All the data processing until this point was conducted in SAS.
The processed dataset was then imported into MATLAB. The predictor variables
mentioned above were not all directly available as a part of the dataset provided by CDC.
Some of them had to be obtained from a combination of other variables available in the
dataset. As the data was obtained from questionnaires and interviews, there were data
elements missing in the dataset. Any missing data elements showed up as NaNs (not a
number). The predictor variables: BMI, smoking, drinking, diet related variables and
ftness related variables had missing data. To avoid misinterpretation of results, data
samples with missing data were deleted.
Data exploration had to be performed after every test run. For instance, the Age
variable ranged between 12-90 years; the BMI variable ranged between 20-40 and weight
was a continuous ranging variable as well. These columns with continuous data needed to
be weighted to standardize their values between 0 and 1. All the other variables used in
the research had values lying between 0 and 1. The logic used to obtain the processed
variables is summarized in the table 3.1 below.
Note that the unprocessed data set had over 3000 variables and about 33,000 data
samples. Based on the relevant variables as determined at the start of the data modeling,
the dataset for desired variables was extracted. SAS was used to ”keep” the desired
variables. The text fle was then imported into MATLAB and it was used for the major
data processing and data merging. Data processing (i.e., eliminating samples with missing
data) reduced the data size considerably.
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After processing, the dataset had 14 cases of individuals with diabetes and 375
cases of individuals with no diabetes. To avoid the problem of class imbalance in a
prediction model, a technique called ’under-sampling’ was used. Under sampling involves
randomly selecting data samples from the higher represented class to match the number of
data samples from the lower represented class (He & Garcia, 2008). Following this, 14
samples were randomly selected from the 375 non- diabetic data samples. 14 diabetic and
14 non-diabetic samples were combined to form a balanced class dataset. After the data
processing was conducted, the dataset had a size of 28x11.
Having 11 variables in a dataset with only 28 samples was a high variable dataset.
To reduce the dimensionality of the data set, Principal Component Analysis (PCA) was
used. Principal component analysis works based on feature extraction. The input variables
of the data set were converted into a set of new variables called principal components
(PCs). The PCs are obtained by orthogonally transforming a set of correlated variables.
The obtained PCs are linearly uncorrelated variables. PCs are transformed in such a way
that the frst PC explains maximum variance of the model. Each succeeding PC then has
maximum variance under the constraint that it is orthogonal to all earlier PCs (Jolliffe,
2011). MATLAB’s PCA function was used to achieve PCs for the current model.
The PCs explaining 95% of the model variance were selected (frst seven PCs).
The dataset of 28 x 11 was reduced to 28 x 8, a combination of seven PCs and one output
variable. The dataset was then divided into training (20x8) and test (8x8) dataset in a
70:30 ratio.

3.1.4 Model development and validation
The classifcation learner application was used in MATLAB and required the
dataset to have only discrete output variables. The output variable in the research was
OGTT, which was converted into discreet values of 0s and 1s based on research by
Schneider, Shaw, and Zimmet (2003).
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Training dataset was used to develop the model and the test dataset was used to
obtain prediction accuracies. The following families of models were developed and the
prediction accuracies were observed.
• Tree based models
• Logistic Regression
• Support Vector Mechanism (SVM)
• Bagged Trees
The predictor variables used in the model were a mixture of categorical variables
and continuous variables. Having a mixture of variable types meant that KNN and
subspace based models could not be developed.
To summarize the work fow along with the size of the data set in each step, the
chart shown in fgure 3.2 was used.
The results from the selected models are available in chapter 4.

3.2 Objective 2 - Non-invasive diabetes detection method
Saliva, breath, tear drop, urine, and sweat are the alternate methods that have the
potential to be used for non-invasive glucose detection. Research was conducted to assess
breath and saliva as two potential methods to detect glucose in a non-invasive way.
Glucose indicators in both breath and saliva were checked for correlation with blood
glucose, ease of sampling, ease of use and cost of detection. The research methodologies
used are discussed below.
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3.2.1 Evaluating breath as a sample for detection of glucose
The correlation between acetone in breath, which is the known biomarker for
glucose concentration and blood glucose, was examined. Based on the review of
literature, acetone in breath was used as the biomarker for diabetes type I by researchers
as show in chapter 2 through fgures 2.1 - 2.5 . Sensors presented in literature for detecting
acetone can detect it down to 0.1ppm.
Breath acetone concentrations in healthy and diabetic patients are signifcantly
different, as established by researchers. However, the correlation between levels of
acetone in breath and diabetes type 2 is not well validated. Studies have shown good
correlation (Deng, Zhang, Yu, Zhang, & Zhang, 2004), while other studies have not
(Greiter et al., 2010). It needs to be noted that the correlation between acetone and blood
glucose is not unanimous yet.

3.2.2 Evaluating saliva as a sample for detection of glucose
Sections below examine the correlation between salivary glucose and blood
glucose. The potential methods of glucose in saliva detection are also highlighted. The
protocols used in the research are outlined.
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Examining the correlation between blood glucose and salivary glucose

The

correlation between salivary glucose (SG) levels and blood glucose (BG) levels has been
tested by researchers. Correlation between BG and SG in healthy subjects is found to be
poor, but the poor correlation can be attributed to the insulin secreted by the pancreatic
beta cells to maintain proper blood sugar levels in the body (Guilbault, Palleschi, &
Lubrano, 1995). A positive correlation of up to r = 0.9 between BG and SG for diabetic
patients was found in the study by (Azizi & Modaberi, 2014).Certain studies did not fnd
signifcant correlation between diabetics BG and SG levels (Carda, Mosquera-Lloreda,
Salom, Gomez de Ferraris, & Peydró, 2006), (Vasconcelos, Soares, Almeida, & Soares,
2010). The difference in fndings by researchers could be attributed to the differences in
the method used for the test, the size and the diversity of the sample used. The possible
reasons for studies not fnding good correlation are further elaborated below.
Du et al. (2016) showed that there is a 15-30 min lag until the change in salivary
glucose is observed after the changes in blood glucose are observed. Failure to incorporate
the lag time in the study for correlation would lead to not fnding good correlation
between BG and SG. Du et al. (2016) also found that not testing SG levels for up to two
hours after a meal would be similar to testing for BG in fasting condition. Acid producing
bacteria in the saliva continuously consume glucose present in saliva. Saliva kept outside
at room temperature for more than two hours causes up to 20% reduction in the amount of
glucose present in it according to Malon et al. (2014). It is important to ensure that fresh
saliva, within two hours of a meal, is used for test to determine correlation between BG
and SG. Ignoring or altering any one of the above mentioned details could have led to bad
correlation between BG and SG found by research groups.
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Bearing the above reasons in mind, the research proceeds to detect salivary
glucose. Jurysta et al. (2009) found a statistically signifcant difference between diabetic
and non-diabetic people. The range found by Jurysta et al. (2009) was 78.7 ± 9.2 µM for
non-diabetic people and 201.9 ± 34.9 µM for diabetic people. This range coincides with
the range determined by Yamaguchi et al. (1998b) such that 8µM is considered as the case
for individuals with hypoglycemia and 220µM is considered for people with
hyperglycemia. The cut off between diabetic and non-diabetic individuals is based on the
range obtained by Jurysta et al. (2009) as mentioned above.
Glucose detection mechanism through saliva Common electrochemical blood glucose
detection methods are based on the following reaction mechanism with the enzyme
glucose oxidase (GOD).
Oxygen

Glucose + GlucoseOxidase −−−−→ H2 O2 + GluconicAcid

(3.1)

H2 O2 generated, as shown by equation 3.1, is used as the indirect measure of
glucose present in blood in commercial lancet devices. A similar concept was applied to
salivary glucose detection. One mole of H2 O2 corresponds to one mole of glucose as
shown by equation 3.1. Based on the salivary glucose range established by Yamaguchi et
al. (1998a), H2 O2 in the range 8µM - 220µM was detected.
Two different approaches were used to detect glucose through H2 O2
colorimetrically.
• Method A: Using Nitroboronic acid in a basic environment (pH 11) and at 800 C (as
shown in section 3.2.2.1) with water as substrate
• Method B: Using Silver Nanoparticles in close to neutral conditions (pH 8) and
room temperature (as shown in section 3.2.2.2)
– Method B1: Detecting H2 O2 that was added directly to the sample solution
using AgNPs.
* Method B1.1: Detection of H2 O2 in water
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* Method B1.2: Detection of H2 O2 in artifcial saliva
– Method B2: H2 O2 generated indirectly from the glucose and glucose oxidase
reaction was detected in the sample solution using silver nanoparticles
(AgNPs).
* Method B2.1: Detection of generated H2 O2 in water
* Method B2.2: Detection of generated H2 O2 in artifcial saliva

3.2.2.1 Method A: Using Nitroboronic acid with water as substrate
Human saliva is known to be constituted of 99.5% water. With the assumption that human
saliva is constitutionally similar to water, the first set of experiments were conducted with
water as the substrate.
Glucose and GOD react in the presence of oxygen to produce H2O2 and gluconic
acid. The reaction between H2 O2 and nitroboronic acid gives rise to a color change. The
intensity of color change is proportional to the concentration of H2 O2 present in the
solution which is in turn a measure of the concentration of glucose (Yamaguchi et al.,
1998b).
The goal of using the nitroboronic acid based method was to provide a proof of
concept for H2 O2 detection in water. Hence, H2 O2 was directly added to water instead of
producing it from glucose and glucose oxidase reaction.
4-Nitrophenyl boronic acid pinacol ester (643890-1G) were purchased from Sigma
Aldrich, USA. 30% H2 O2 (H325-500), Sodium Hydroxide pellets(S318-500) and
Methanol (A412-4) were purchased from Thermo Fisher Scientifc, USA. MilliQ water
was used for all dilutions that needed water. Test tubes with lids (from Fischer Scientifc)
were used for all experiments.
The Nitroboronic acid based detection was an adaptation from Su, Wei, and Guo
(2011)’s H2 O2 detection method. Su et al. (2011) demonstrated results with H2 O2
detection in a linear range from 1 to 40µM. The procedure highlighted by Su et al. (2011)
was extended to test range from 8µM - 220µM H2 O2 in the author’s research.
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At frst, the stock solution of 4- Nitrophenylboronic acid pinacol ester was made in
Methanol (1mM, 250ml). Next, a pH 11 buffer solution was made using NaOH. The
dilution solution was made by mixing 50ml of nitrophenylboronicacid stock solution and
bringing the volume up to 1L using the buffer solution (Su et al., 2011).
The reaction mechanism of 4-nitrophenylboronic acid with H2 O2 to form
nitrophenol (pale yellow in color) as shown in equation 3.2 occurs.
H O

2
(O2 N)C6 H4 (B(OH)2 ) −−2−→
O2 NC6 H4 OH

(3.2)

H2 O2 of the concentrations 220µM, 100µM, 50µM, 25µM, 8µM were made by
dissolving appropriate proportions of 30% H2 O2 in milliQ water. 5ml of H2 O2 solution
(of each concentration in individual test tubes) was mixed with 5ml of dilution solution. A
blank test tube with 5ml dilution solution and 5ml milliQ water was also prepared. The
test tubes with different concentrations of H2 O2 and the blank test tube were incubated in
a hot water bath at 800 C for 10 minutes. A noticeable change in color (from colorless to
pale yellow) was observed in all the sample test tubes. The intensity of yellow varied
across the samples. Lower concentration (8µM) had a lighter yellow hue when compared
to hue of higher concentration(220µM) of H2 O2 . A fowchart explaining the above
protocol is available in Fig 3.3.
The results from the Nitroboronic acid based H2 O2 detection are available in
chapter 4. The next logical step based on the results of direct H2 O2 detection was to detect
H2 O2 using the AgNPs method.
3.2.2.2 Method B: Experiments using AgNPs method
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After conducting an initial experiment with the nitroboronic acid method, an
experiment was conducted to detect H2 O2 using AgNPs. Nanoparticles are typically
particles in the size range 1 - 100nm. Nanoparticles are generally made from noble metals
like gold and silver. Nanoparticles are known for their high surface to volume ratio. The
high surface to volume ratio enhances reactions by providing more area for the reaction
mechanism to occur. The concept of enhancement of reaction surface to achieve data that
gives a larger peak amplitude was used.
Silver nanoparticles (Ag NPs) were fabricated in lab and used for all the
experiments. Ag NPs made in lab by Logan Kurgan were used (Unpublished work by
Logan Kurgan, Integrated Sensing and Smart Solutions Lab, Purdue University). The Ag
NPs had a size range of 1-100nm with a mean particle size of 10nm. The nano particles
were characterized using a Zetasizer (Malvern Zetasizer Nano ZS, available at Birck
Nanotechnology Center, Purdue University).
Method B1: Detection of H2 O2 that was added directly to the sample using AgNPs
method The detection of H2 O2 that was added directly to the sample was further sub
divided into two experiment groups.
1. Method B1.1: Detection of H2 O2 that was added directly to the sample in water
using AgNPs method.
2. Method B1.2: Detection of H2 O2 that was added directly to the sample in artifcial
saliva using AgNPs method.
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3.2.2.2.1. Method B1.1: Experiments to detect H2 O2 in water directly using AgNPs
method

H2 O2 in fve different concentrations - 220µM, 100µM, 50µM, 25µM, 8µM were
prepared using 30% H2 O2 in milliQ water. 300µL of H2 O2 and 700µL of Ag NPs were
added to a test tube. A series of fve such test tubes was created for fve different H2 O2
concentrations. A blank was made using 700µL of Ag NPs and 300µL of milliQ water.
The fowchart representing protocol used for H2 O2 detection in water (using AgNPs) is
shown in fgures 3.4 , 3.5. Details of all the experiments conducted with this particular
method are available in table 3.2.

3.2.2.2.2. Method B1.2: Experiments to detect H2 O2 in artifcial saliva (AS) directly using
AgNPs

A set of experiments was conducted to detect H2 O2 in AS using the AgNPs
method. AS was prepared using Ringer’s AS protocol (Othman & Etteyeb, 2017) which is
based on the constitution of human saliva - assuming that the mouth is not undergoing any
harsh conditions (like infections or ulcers). The composition of Ringer’s artifcial saliva
solution is below in table 3.3.
NaCl, KCl, CaCl2 .2H2 O, NaHCO3 were purchased from Thermo Fischer
Scientifc, USA. All the salts were added to a cylindrical fask and the volume was
brought up to 1L. Each time AS was needed for any experiment, it was made in 1L
batches and used.
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Glucose concentrations of 220µM, 100µM, 50µM, 25µM, 8µM were also
prepared using 30% H2 O2 in artifcial saliva. The blank for the experiment was AgNPs +
GOD (700µL) and water (300µL). The sample for experiments with AS was AgNPs +
GOD (700µL) and AS with glucose at 5 different concentrations in 5 different test
tubes(300µL). The fowchart outlining the protocol for the experiments conducted to
detect H2 O2 in AS using the AgNPs method are outlined in fgure 3.6. Two experiments
were conducted in this section. Details of the experiments conducted are available in table
3.4.
Method B2: Detection of H2 O2 that is generated from the glucose and glucose
oxidase reaction (GOD) using AgNPs method

After detecting H2 O2 that was added

directly to the sample solution in both water and artifcial saliva, the next logical step was
to detect H2 O2 that is generated from the glucose and glucose oxidase reaction - as would
be the situation in real life where glucose is present in saliva. This method was further
categorized into two experiment groups.
1. Method B2.1: Detection of H2 O2 that was generated from glucose and GOD
reaction in water
2. Method B2.2: Detection of H2 O2 that was generated from glucose and GOD
reaction in artifcial saliva.

3.2.2.2.3. Method B2.1:Detection of H2 O2 that was generated from glucose and GOD
reaction in water using AgNPs

As shown by equation 3.1, dextrose (D- glucose) binds with the enzyme glucose
oxidase to release H2 O2 and gluconic acid.
Glucose oxidase (G7141-50KU) was purchased from Sigma (Sigma Aldrich, St.
Louis, USA) and D-Glucose (D16-1) was purchased from Thermo Fisher Scientifc, USA.
AgNPs made in lab were used. Glucose Oxidase (GOD) powder was stored at -200 C and
GOD solutions were stored at -40 C.
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Glucose oxidase powder was mixed with milliQ water and a solution was made.
Glucose solutions in milliQ water of concentrations 220µM, 100µM and 8µM were
prepared using D-glucose powder and milliQ water.
Blank solution was made by mixing water, AgNPs and GOD solutions. A sample
solution was made by mixing glucose solution, GOD solution and AgNPs. A series of
sample test tubes was set up to test different glucose concentrations. Color change was
quantifed using the NanoDrop spectrometer.
For the initial experiments, glucose oxidase solution was made by mixing GOD
powder in water. The protocols for the frst two experiments which use GOD solution in
water are shown in fgures 3.7 and 3.8. In the next set of experiments, GOD powder was
added directly to silver nanoparticles solution instead of water (Details in fgure 3.9). This
reduced the total volume of the sample solution which led to darker color. The water in
the GOD solution was diluting the sample and reducing the intensity of the muddy sample
solution color. The volumes of different solutions also had to be adjusted to get the
optimal solution volume. A total of seven replicates were tested for each glucose
concentration in water. The fowchart (fg 3.10) outlines the protocol used. A total of eight
experiments were conducted and the details of the experiments conducted are available in
table 3.5.

3.2.2.2.4. Method B2.2: Detection of H2 O2 that was generated from glucose and GOD
reaction in artifcial saliva in AgNPs

A set of experiments were conducted to test the H2 O2 generated from the glucose
and GOD reaction in artifcial saliva. AS was prepared using Ringer’s Protocol as
described above.
Glucose concentrations (220µM, 100µM and 8µM) were prepared in artifcial
saliva. The sample solution contained 1400µL of AgNPs + GOD and 1400µL of glucose
in AS. The aim was to test the linearity in peak intensities at different salivary glucose
concentrations. The blank was 1400µL of AgNPs + GOD and 1400µL of water.
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The protocol is outlined in fg 3.11.
Initially, AS that was prepared and stored was used along with some freshly
prepared AS for the frst three experiments. Upon examining the results, a decision was
made to conduct the next set of experiments only with freshly prepared AS. This was done
to eliminate the effects of fresh AS vs old AS. To eliminate any impact of reaction time,
an experiment was conducted and tested for color change at exactly 5 minutes for each
concentration. A total of six experiments were conducted with this method. Details of the
experiments conducted are available in table 3.6.
Instrument Used A Nanodrop spectrometer (shown in fgure 3.12) by Thermo Fischer
Scientifc, USA (ND-1000) was used to quantify the change in color for all the
experiments.
Protocol for using the NanoDrop spectrometer:
1. The sample pedestal needs to be loaded with 1.5-2µL water to initialize the
instrument
2. The instrument then needs to be blanked by using a blank sample (1.5-2µL volume)
3. The instrument can then be used to measure any sample concentration(1.5-2µL
volume)
4. At any point, if the baseline seems to be going upwards, the instrument can be
re-blanked

3.3 Summary
For chapter three, the methodologies used to model the data and the protocols used
to detect glucose in water and in artifcial saliva were discussed in detail.
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Figure 3.1. Flowchart representing data processing in SAS 9.4®software

Figure 3.2. Flowchart representing work fow for Objective 1
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Figure 3.3. Flowchart representing the protocol for H2 O2 detection using 4-nitrophenyl
boronic acid
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Figure 3.4. Flowchart representing the protocol for detecting H2 O2 using Nanoparticles
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Figure 3.5. Flowchart representing the protocol for detecting H2 O2 in water using
Nanoparticles

42

Figure 3.6. Flowchart representing the protocol for detecting H2 O2 in artifcial saliva
using Nanoparticles
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Figure 3.7. Flowchart representing the protocol for detecting H2 O2 indirectly using
Nanoparticles

44

Figure 3.8. Volume Optimization protocol fowchart
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Figure 3.9. GOD powder in AgNPs protocol fowchart
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Figure 3.10. Flow chart outlining the protocol for the 200µM glucose experiment with
AgNPs and GOD
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Figure 3.11. Flow chart outlining the protocol for experiments with glucose in artifcial
saliva

Figure 3.12. NanoDrop Spectrometer. Courtesy of the Freeman Lab

48

Table 3.1. Summary of the pre-processing for predictor variables
Name of the input Description of pre-processing
variable
BMI
Used as is Deleted NaNs
Lab
Men : >= 40mg/dL. Women>= 50 mg/dL is required. <40
Cholesterol(HDL) for men and <50 for women is a risk (NIH).
Age
Used as provided by NHANES
Gender
Used as provided by NHANES
Ethnicity
Whites: Not at risk. Non- whites: At risk
BP
>120 or >80 is risky. <=120 and <=80 is not risky.
Deleted NaNs. (ADA)
Smoking
If people dont smoke at all or used to smoke but quit now, I
set total smoking = 0. If people smoke now, multiplied the
number of cigars per day by number of days smoked per
week. Deleted NaNs.
Drinking
For men: <= 2 drinks per day is ok. For women: <=1
drink/day is ok. Deleted NaNs.(ADA)
Overall Diet
If saturated fat is >= 10% of total energy, it is a risk. If diet
cholesterol >300 then it is a risk. If total fat is >= 30% of
total energy, it is a risk. If carbs >= 60% of total energy,
it is a risk. If protein is >35% of total energy or <10% of
total energy, it is a risk. If diet fber is >38 for men or >25
for women, it is a risk. Deleted NaNs. (ADA, USDA)
Overall Fitness
If weekly exercise is <150 mins, it is risky. If doctor asked
to increase exercise but the individual has not increased any
exercise, then it is a risk. Deleted NaNs. (ADA)
High
Calorie For men >3200 calories per day is risky. For women >2400
Consumption
calories per day is risky.(ADA)

Table 3.2. Summary of experiments for detection of H2 O2 directly using AgNPs method
in water
S.No. Sample solution
Blank solution
Repl.
1
220µM , 100µM , 50µM , 25µM Water (300µL) + AgNPs (700µL) 1 for
every
, 8µM H2 O2 in water (300µL) +
conc.
AgNPs (700µL)
2
220µM , 100µM , 50µM , 25µM Water (300µL) + AgNPs (700µL) 1 for
, 8µM H2 O2 in water (300µL) +
every
conc.
AgNPs (700µL)
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Table 3.3. List of chemicals with quantities to make artifcial saliva (Othman & Etteyeb,
2017)
Name of Chemical
Quantity(g/L)
Sodium Chloride (NaCl)
9
Pottasium Chloride (KCl)
0.4
Calcium Chloride Dihydrate (CaCl2 . 2H2 O) 0.134
0.2
Sodium Bicarbonate (NaHCO3 )
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Table 3.4. Summary of experiments for detection of H2 O2 directly using AgNPs method
in Artifcial Saliva
S.No. Sample solution
Blank solution
Repl.
1
220µM , 100µM , 50µM , 25µM Water (300µL) + AgNPs (700µL) 1 for
every
, 8µM H2 O2 in AS (300µL) +
conc.
AgNPs (700µL)
2
220µM , 100µM , 50µM , 25µM Water (300µL) + AgNPs (700µL) 1 for
, 8µM H2 O2 in AS (300µL) +
every
conc.
AgNPs (700µL)

Table 3.5. Table showing the summary of experiments conducted with AgNPs method to
detect indirectly generated H2 O2 in water
S.No. Sample solution
Blank solution
Repl.
1
Glucose sol (700µL)+ GOD Water (700µL) + GOD solution 1
sol (300µL)+ AgNPs in water (300µL) + AgNPs (700µL)
(700µL)
2
Glucose sol (700µL) + GOD sol Water (700µL) + GOD solution 1
(700µL) + Ag NPs in water (700µL) + AgNPs (700µL)
(700µL)
3
Glucose sol (1400µL) + GOD Water (1400µL) + GOD solution 1
sol (1400µL) + Ag NPs in water (1400µL) + AgNPs (1400µL)
(1400µL)
4
Glucose (1400µL) + GOD in Water (1400µL) + GOD solution in 1
AgNPs (1400µL)
AgNPs (1400µL)
5
220 µM Glucose (1400µL) + Water (1400µL) + GOD solution in 4
GOD in AgNPs (1400µL)
AgNPs (1400µL)
6
8 µM Glucose (1400µL) + GOD Water (1400µL) + GOD solution in 4
in AgNPs (1400µL)
AgNPs (1400µL)
7
220 µM and 8µM Glucose Water (1400µL) + GOD solution in 3, 3
(1400µL) + GOD in AgNPs AgNPs (1400µL)
(1400µL)
8
100 µM Glucose (1400µL) + Water (1400µL) + GOD solution in 4
GOD in AgNPs (1400µL)
AgNPs (1400µL)
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Table 3.6. Summary of experiments for detection of H2 O2 generated indirectly using
AgNPs method in Artifcial Saliva
S.No. Sample solution
Blank solution
Repl.
1
100 µM Glucose in AS (1400µL) Water (1400µL) + Ag NPs + GOD 4
+ Ag NPs + GOD (1400µL)
(1400µL)
2
220 µM and 8µM Glucose in Water (1400µL) + Ag NPs + GOD 4, 4
AS (1400µL) + Ag NPs + GOD (1400µL)
(1400µL)
3
100 µM Glucose in AS (1400µL) Water (1400µL) + Ag NPs + GOD 4
+ Ag NPs + GOD (1400µL)
(1400µL)
4
220 µM, 100 µM and, 8µM Water (1400µL) + Ag NPs + GOD 3
Glucose in AS (1400µL) + Ag (1400µL)
NPs + GOD (1400µL)
5
220 µM, 100 µM and, 8µM Water (1400µL) + Ag NPs + GOD 3
Glucose in AS (1400µL) + Ag (1400µL)
NPs + GOD (1400µL)

52

CHAPTER 4. RESULTS
Chapter 4 covers the results obtained from the data modeling in the frst section. In
the second section of chapter 4, results from glucose detection in water and saliva are
outlined. The interpretability of the obtained results is also discussed in chapter 4.

4.1 Objective 1 - Computational Prediction Model Results and Discussion
A computational prediction model was developed with the following inputs and
output:
Inputs:
1. BMI
2. Lab Cholesterol (HDL)
3. Age
4. Gender
5. Ethnicity
6. BP
7. Smoking
8. Alcohol Consumption
9. Overall Diet
10. Overall Fitness
11. High Calorie Consumption
Output
1. Glucose levels (Standardized to 0 or 1 for No diabetes and Diabetic based on oral
glucose standard test cut offs (Davidson, Schriger, Peters, & Lorber, 2000).
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4.1.1 Objective 1 - Computational Model: Results and Discussion
The use of principal component analysis (PCA) ensured that all the 11 input
variables were incorporated in the model. Eliminating risk factors based on signifcance as shown by the models in table 2.1 - uses feature elimination. PCA used in the present
model ensures feature extraction which retains useful information from all the variables.
The complexity of the dataset in the current model required an approach which was more
sophisticated compared to regression based prediction. The prediction outputs obtained
through the current models in chapter 3 incorporate all the inputs and produce a more
accurate output. The model can be used by patients, doctors and health care technologists
after it has been validated on a bigger dataset.
The prediction accuracies from the selected models based on the test dataset are
shown in table 4.1.
The other models that were created but not selected for potential use are shown in
table 4.2. Although some of the models in table 4.2 have good prediction accuracies, they
were rejected due to other factors like model interpretability, kernel scale and, model
performance with large datasets. Other machine learning models like KNN were also
considered but were not used because the dataset had both discrete and continuous
variables.
Computational models were considered based on the model properties complexity, interpretability of results, number of splits used and the ft of the model. Data
related to documentation of the models was collected from Matlab’s Documentation
website (Mathworks, 2018, (Accessed Online February 2018)).
The categories of models considered were:
1. Tree Based
2. Logistic Regression
3. Support Vector Mechanism
4. Bagged Trees/ Random Forest
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The tree based models were further divided into three categories: a) complex b)
medium c) simple
Maximum number of splits in a tree based model is defned as the number of
branches the tree can have. When growing a decision tree, the simplicity and predictive
power of the tree needs to be considered. Maximum number of splits is used to set the
depth of a tree to avoid a model from over-ftting the dataset.
Maximum number of splits is different for the above three tree based models. A
complex tree can have a maximum of 100 splits. A medium tree can have a maximum of
20 splits and a simple tree can have a maximum of four splits. Amongst the three models,
the medium tree suited dataset based on the size of the dataset (28x8). Complex tree
would increase the number of splits to more than 20 and this would increase the chances
of the model over ftting and so it was not used. The simple tree could only do four splits
and cannot model the complexity of the dataset accurately. The simple tree based model
was not used based on the aforementioned reason. The medium tree ft the requirements
for the dataset used in the research and was selected and used for further analysis.
Logistic Regression is easy to interpret and can be used when the model has only
two output classes (Mathworks, 2018, (Accessed Online February 2018)). A drawback for
the logistic regression model is that it has low model fexibility. The scope of extending
the logistic regression model to no diabetes, pre-diabetes and diabetes cases is impossible
which led to the decision of not selecting logistic regression for further analysis.
SVM was further divided into the following six categories: a) linear b) quadratic c)
cubic d) fne gaussian e) medium gaussian f) coarse gaussian
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Linear SVM is capable of making simple linear separation for the classes. A
linearly separable data is one where all the data points can be separated into two classes
using a hyperplane. Linear separation of classes does not suit a complex dataset, so it was
rejected. Fine gaussian SVM and coarse gaussian SVM have very low and very high
kernel scale respectively. Medium gaussian SVM has medium interpret-ability with kernel
scale set to square root of number of predictor variables and it was chosen for future
analysis. Although quadratic SVM and cubic SVM have a complex model interpretability,
they were chosen for future analysis due to their potential. Both quadratic and cubic SVM
models show improved responses with large datasets, which can be used if a bigger
dataset becomes available.
The bagged trees model is named after the random forest model (Mathworks,
2018, (Accessed Online February 2018)). Bagged trees model works by generating
randomly a fxed number of decision tree learners. Fixed number of decision trees are
created and the prediction is based on the mode of the prediction results of the individual
trees. Bagged trees model works well for the model with the current dataset size and will
work better when a bigger sample set becomes available. Keeping the potential of the
model with a larger dataset in mind, the bagged trees model was selected for future
analysis.
To summarize, the medium tree, medium Gaussian SVM, quadratic SVM, cubic
SVM and bagged trees models were selected as potential models to use when a bigger
dataset becomes available. The dataset used to perform the data analysis is not big enough
to draw conclusive results. However, the methodology used can be extended to a bigger
dataset. The models selected as shown in table 4.1 are chosen to suit a bigger dataset for
future work.

4.2 Objective 2 - Non-invasive diabetes detection: Results and Discussion
The results and discussion related to glucose sensing using different methods are
discussed here.
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4.2.1 Results and discussion for Breath as a sample for diabetes detection
Human breath was the frst non-invasive sample researched for potentially
detecting glucose in the body. Acetone in breath was rejected as a potential method for
diabetes detection based on the following reasons.
When the human body doesn’t have enough insulin to convert the glucose into
energy, it starts burning fats. When fats are burned, ketones are released. Acetone is one
among the three ketones released by the human body. Although acetone is present in the
breath of people having diabetes, it is also released when people are fasting or eating
foods that are rich in fats and not sugars (Prabhakar et al., 2015). Acetone is released
every time the body burns fat for energy instead of using glucose. One of the reasons why
acetone is not considered a reliable marker is the unselective nature towards diabetes.
The other reason for not selecting breath based diagnosis for diabetes is the
ketoacidosis phase occurs when an individual is heavily diabetic. Acetone can therefore
not be used to diagnose or screen any pre-diabetic cases or early diabetes cases.
Gestational diabetes is a condition similar to type-2 diabetes. Thus, using breath of
the patient for diagnosing diabetes(type-2) or GDM was concluded to be inappropriate.

4.2.2 Saliva as a sample for diabetes detection
Two different approaches were used to detect glucose at the salivary glucose level.
Glucose and GOD react in the presence of oxygen to produce H2 O2 and gluconic
acid as shown in equation 3.1. The produced H2 O2 was aimed at being detected. The
H2 O2 detection was conducted in two ways.
• Method A: Using Nitroboronic acid in a basic environment (pH 11) and at 800 C (as
shown in section 3.2.2.1) with water as substrate
• Method B: Using AgNPs in close to neutral conditions (pH 8) and room
temperature (as shown in section 3.2.2.2)
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– Method B1: Detecting H2 O2 that was added directly to the sample solution
using AgNPs.
* Method B1.1: Detection of H2 O2 in water
* Method B1.2: Detection of H2 O2 in artifcial saliva
– Method B2: H2 O2 generated indirectly from the glucose and glucose oxidase
reaction was detected in the sample solution using AgNPs.
* Method B2.1: Detection of generated H2 O2 in water
* Method B2.2: Detection of generated H2 O2 in artifcial saliva
The results from the methods listed above are presented in the section below.
4.2.2.1 Method A: Using Nitroboronic acid with water as substrate
The aim of using the nitroboronic acid based method was to provide a proof of
concept for H2 O2 detection in water. For the purpose of this experiment, H2 O2 was
directly added to water instead of producing it from glucose and glucose oxidase reaction.
The experiment conducted using bulk solution of Nitroboronic acid and H2 O2 are
shown in fgures 4.1(a) and 4.1(b). Data were collected from the NanoDrop Spectrometer
and processed. The data obtained from the nanodrop were normalized in its raw form. The
nanodrop spectrometer software performs automatic data normalization based on the
lowest data value obtained in the 400 - 750nm range. The raw data was un-normalized in
excel by using the normalization value provided by the nanodrop spectrometer software.
The minimum value was then computed in the 220 - 750nm range and if the minimum
value was negative, then it was added to all the data samples for baseline correction.
Absorption data (range 0-1) from the nanodrop was converted to percentage
transmission data (range 0-100%) using the equation shown in equation 4.1. The equation
was obtained by taking log inverse of the absorbency equation (Scientifc, 2010).
T % = 10−A ∗ 100

(4.1)
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From fgure 4.1(a), it can be seen that the absorption intensity for 220µM, 100µM,
50µM, 25µM and 8µM corresponds to approximately 5.5%, 4%, 3%, 1.5% and 0.5%
absorbency respectively. There is a clear visual distinction between different levels of
salivary glucose concentration in the 300-450nm wavelength range as seen in the plots (fg
4.1(a) and 4.1(b)). The distinction is a positive indicator of the ability to detect glucose in
saliva using a colorimetric approach.
4.2.2.2 Method B: Experiments using AgNPs method
After conducting experiments with nitroboronic acid, AgNPs were used to test
H2 O2 detection. The idea to use AgNPs was primarily adopted because of their high
surface to volume ratio. A series of experiments was conducted using AgNPs. All the
experimental results are discussed in the sections below.
Method B1: Detection of H2 O2 that was added directly to the sample using AgNPs
method The detection of H2 O2 that was added directly to the sample was further sub
divided into two experiment groups.
1. Method B1.1: Detection of H2 O2 that was added directly to the sample in Water
using AgNPs method.
2. Method B1.2: Detection of H2 O2 that was added directly to the sample in Artifcial
Saliva using AgNPs method.

4.2.2.2.1. Method B1.1: Detection of H2 O2 added directly in water using AgNPs method

Experiments were conducted to test for H2 O2 in water using AgNPs. The results
obtained from the experiments are shown in fgures 4.2(a) and 4.2(b) (Absorption and
Transmission curves) and fg 4.3 (Only absorption curves).
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From fgure 4.2(a), it can be seen that the absorption intensity for 220µM, 100µM,
50µM, 25µM and 8µM corresponds to approximately 11%, 7%, 5%, 3% and 1%
absorbency respectively. The absorbency peaks are visually well separated (as can be seen
in fgure 4.2(a)).
Nanoparticles are known to enhance reaction surfaces due to their high surface to
volume ratio (Agnihotri, Mukherji, & Mukherji, 2014). In this case, nano particles are
enhancing the optical pathway to give better absorption intensities. The results summary is
shown in table 4.3. In this experiment, it is concluded that the nanoparticles based method
is able to detect H2 O2 in water colorimetrically in the salivary glucose range established
by Yamaguchi et al. (1998b). This method also allows clear differentiation between
diabetics (7% absorbency at 100µM) and non-diabetics (11% absorbency at 220µM)
based on the cut-off values established by Jurysta et al. (2009) (78.7 ± 9.2 µM for
non-diabetic people and 201.9 ± 34.9 µM for diabetic people). It is to be noted that the
interacting compounds (glucose or GOD) are not conjugated to the silver nanoparticles.
As can be seen by comparing the fgures 4.2(a) and 4.1(a), the peak absorption
amplitudes are higher when nanoparticles are used (11% absorbency for 220µM) to detect
the H2 O2 in water than when nitroboronic acid is used (6%absorbency for 220µM). Based
on this comparison, Nanoparticles based detection method was used for future
experiments.

4.2.2.2.2. Method B1.2: Detection of H2 O2 directly in artifcial saliva (AS) using AgNPs
method

Two experiments were conducted to detect H2 O2 in AS using the AgNPs method.
The tests were conducted for H2 O2 concentrations at 8µM, 25µM, 50µM, 100µM and
220µM.
The results of the frst experiment are shown in fgure 4.4 (all fve concentrations
are represented on the same graphs with fve curves). The results of the second experiment
are shown in fgure 4.5 (each concentration is represented on a different graph).
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The results indicate that the peaks observed in AS (as substrate) have absorbency
of approximately 1 - 2% for all concentrations of H2 O2 . The peaks are not differentiable
(visually) for different concentrations of H2 O2 in AS.
Test tubes containing sample solutions were originally brown in color. The sample
solutions started to turn colorless after a reaction time of 30 minutes. Such a change in
color was not observed with H2 O2 in water. The loss of color or color fading (solution is
mostly transparent) is the reason why the peak intensities did not clearly show up.
The H2 O2 is postulated to react with Ringer’s solution in a way that leads to
dissolution of the H2 O2 molecule into water and oxygen. Similar results were obtained by
researchers (Chen, Hai, Chen, & Wang, 2014) who observed color fading to increase
proportionately with the increase in H2 O2 concentration. The property of color fading
shows that there is potential to detect H2 O2 colorimetrically. However, in this experiment,
the H2 O2 faded the color of the nanoparticles completely in artifcial saliva which led to
no peaks in the UV - Vis absorption spectrum.
From this experiment it can be concluded that direct addition of H2 O2 to artifcial
saliva is not being detected using the silver nanoparticles method.
On comparison with the results from H2 O2 detection in water using AgNPs , H2 O2
in AS is not being detected as clearly as H2 O2 in water (Figure 4.6 for comparison). In
fgure 4.6, a comparison of H2 O2 in water and in AS at the same H2 O2 concentration is
shown. The summary for these experiments is shown in table 4.4.
Method B2: Detection of H2 O2 that is generated from the glucose and glucose
oxidase reaction using AgNPs method

The method was further categorized into two

experiment groups. The only difference between the two methods is the substrate - water
vs artifcial saliva.
1. Method B2.1: Detection of H2 O2 that was generated from glucose and GOD
reaction in water
2. Method B2.2: Detection of H2 O2 that was generated from glucose and GOD
reaction in artifcial saliva.
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4.2.2.2.3. Method B2.1:Detection of H2 O2 that was generated from glucose and GOD
reaction in water using AgNPs

Eight experiments were conducted to detect the H2 O2 generated from the glucose
and glucose oxidase enzymatic reaction. The experiment was conducted at three different
salivary glucose concentrations - 220µM, 100µM and 8µM. The results for the eight
experiments are shown in fgures 4.7 - 4.21. The samples were tested at different time
instances (5, 30 and 60 minute instances). Graphs at different time instances for the same
glucose concentration show that the peak absorption pattern in the UV - Vis region is
preserved over time. The highest absorption intensity is obtained after 60 minutes for all
glucose concentrations (6% absorbency for 220µM glucose after 60 minutes). The
summary of the results is shown in table 4.5.
Comparing the fgures 4.24 with 4.21 - it can be concluded that the absorption
curve for 100µM (3% absorbency) lies linearly between the absorption curves of 220µM
(6% absorbency) and 8µM (1% absorbency). From the comparison, it can be concluded
that salivary glucose detection in water using silver nanoparticles is linear over the
salivary glucose range of 8-220µM as the absorption peaks increase proportionally with
increase in glucose concentration.
Based on the results from the experiments so far, it was concluded that 1400µL of
AgNPs + GOD solution was the most optimal. All future experiments were conducted
with 1400µL of AgNPs + GOD solution volume. The results of experiments in this
section indicate that the presence of H2 O2 in water can be detected colorimetrically in the
salivary glucose range of 8µM - 220µM. It can also be concluded that the method also
allows clear differentiation between diabetics and non-diabetics based on the cut-off
values established by Jurysta et al. (2009) (78.7 ± 9.2 µM for non-diabetic people and
201.9 ± 34.9 µM for diabetic people).
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The absorption and transmission curves for the three glucose concentrations are
visually distinguishable as can be seen from the graphs. However for experiments 4.7 4.21 (maximum 6% absorbency at 220µM after 60 mins), the peak amplitudes are not as
high as the peak amplitudes obtained from direct H2 O2 experiments 4.3 (maximum 11%
absorbency at 220µM after 60 mins). The reasons for absorption peaks not being as high
as the absorption peaks from direct H2 O2 detection are multi fold. First, the H2 O2 being
generated from glucose and GOD needs oxygen to be produced. Second, the amount of
GOD provided for the reaction may be insuffcient. Third, the volume of glucose and
AgNPs may play a vital role in the produced absorption units. And fnally, the reaction
between glucose and glucose oxidase could be time-dependent. A combination of two or
more of the above mentioned reasons is postulated to affect the amplitude of the a.u.
Similar results have been obtained by researchers who have tested for both H2 O2 directly
and glucose using the enzymatic approach (Nguyen et al., 2018), (Chen et al., 2014).

4.2.2.2.4. Method B2.2: Detection of H2 O2 that was generated from glucose and GOD
reaction in artifcial saliva in AgNPs

Six experiments were conducted to test the H2 O2 generated from the glucose and
GOD reaction in artifcial saliva.
The experiments in this section were conducted at three glucose concentrations 220µM, 100µM and 8µM. The results summary is shown in table 4.6. The results from
these experiments are shown in fgures 4.25 - 4.39.
Effects of testing with the same blank solution vs different blank solutions were
tested in one of the six experiments. Another experiment was used to test the effect of
fresh AS preparation vs old AS preparation. The fnal experiment in this set of
experiments was conducted such that all samples were measured exactly at 5 minutes.
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As can be seen from the results, the experiments with artifcial saliva are highly
time sensitive. The graphs don’t keep up their patterns with time unlike the experiments
with water as substrate (fg 4.25 - 4.39). Each time the nanodrop spectrometer was used to
make a sample measurement, about 15 seconds of time was required. The delay leads to a
cumulative delay of about a minute or two until the all the samples of one specifc
concentration are tested. To avoid the delay, the last experiment was conducted such that
testing was performed at exactly 5 minutes after each sample of a concentration was
prepared.
The results from the exact fve minute testing are shown in fgure 4.39. The peak
absorbencies for 220µM, 100µM and 8µM are 6%, 3% and 4.5% respectively. The
results show that the peaks from exact 5 minute tests are very similar to those from
experiment 4.38 results (peak absorbencies for 220µM, 100µM and 8µM are 5.5%, 3.5%
and 5% respectively). Unlike the results of glucose in water, glucose in AS does not give a
clear distinction of the salivary glucose level as established by Yamaguchi et al. (1998b).
Based on Jurysta et al.’s work and based on the results from the last two experiments in
this set (fg 4.38 and 4.39), we can see that there is a distinction between peaks of diabetic
salivary glucose and non-diabetic salivary glucose. However, more work is needed to
understand the trends and patterns followed when artifcial saliva is used as the substrate.
The experiment may give different results with AS prepared using a different protocol.
The results with regards to artifcial saliva require more testing and analysis of the data.
Table 4.7 summarizes the section-wise results for the glucose detection research
conducted using AgNPs.
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4.3 Exploration of potential pathways for glucose detection in Saliva
Extensive literature review was conducted to explore potential pathways to
non-invasively detect glucose. The work conducted by other researchers can be classifed
under six broad categories. The categories are as follows:
1. Boronic Acid functionalized Nanoparticles
2. Nanoparticles based
3. Microfuidic based
4. Electrochemical methods
5. Florescence based
6. Protein based
Within the six methods listed above, the categorization is further done based on the
medium in which the research was conducted. The mediums used by different researchers
are:
1. Blood based or serum based
2. Water based or aqueous solution based
3. Urine based
4. Saliva based
Boronic acid functionalized nanoparticles and nanoparticles based were the two
methods that were considered here. A summary of the work presented by other
researchers in the feld of boronic acid functionalized nanoparticles and nanoparticles
based methods is shown in table 4.8 and elaborated below.
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The covalent product of diols and boronic acid is called a boronate ester (Pappin,
Kiefel, & Houston, 2012). The affnity of boronic acid groups towards diols has been used
to sense mono saccharides and poly-saccharides. Boronic acids display different affnities
with different carbohydrates which allows researchers to selectively detect specifc
carbohydrates (J. Zhang, Geddes, & Lakowicz, 2004). Nanoparticles are commonly made
using metallic compounds like gold and silver. The combination of boronic acids capped
with specifc nanoparticles like gold nanoparticles or silver nanoparticles has been used by
researchers to enhance the detection sugar sensing signals.
Recently, the enzyme mimicking properties of nanoparticles has been explored.
Gao, Wu, and Di (2017) used gold nano particles to bind with glucose and then used silver
nanoparticles to detect the glucose that bound with the gold nanoparticles. This work did
not use the enzyme glucose oxidase which led to enzyme free detection. Enzyme free
detection is useful as it gives the biosensor a longer shelf life and has convenient storage
options. The enzyme free approach is one of the potential pathways that can be used to
detect glucose in saliva.
Coupling of nanoparticles with quantum dots has been reported (Chen et al.,
2014), (Nguyen et al., 2018). Coupling nanoparticles and quantum dots leads to higher
stability in the nanoparticles. The quantum dots are also extremely rich in oxygen which
enables color fading. The extent of color fading depends on the H2 O2 present in the
solution which is a measure of the amount of glucose present in the sample. The color
fading property is a potential method of quantifying the concentration of glucose
colorimetrically (Chen et al., 2014). Chen et al. (2014) reported a linear range of detection
of 0.5 . 10−3 - 0.4mM with a limit of detection (LOD) of 0.17µM.
Nguyen et al. (2018) used human urine as the sample. They reported a linear range
of detection of 0.5 - 8mM and a LOD of 30µM.
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Using different shapes of nanoparticles like nanostars or nanotubes to bind with
glucose oxidase has been another method of sensing glucose. Binding the enzyme GOD
with nanoparticles gives rise to highly sensitive biosensors that can be applied to salivary
glucose detection (Al-Ogaidi et al., 2014). Nanoparticles based sensors have mostly been
used in aqueous medium. Fabricated biosensors that use nanoparticles fabricated on a
glass flm using layer by layer assembly were reported (Teerasong et al., 2015). The glass
flm based sensors use less sample solution and can used as hand held, disposable sensors.
Not all of the sensors presented in table 4.8 have the potential to be used as hand
held devices. But with colorimetric detection, image processing can be used in
combination with a cell phone camera. The developed biosensors have the potential to be
converted to sensitive hands on devices that can be used for salivary glucose detection.
Based on the research summary shown in table 4.8, the AgNPs/GQDs method has
the potential to detect glucose in artifcial saliva. One attempt was made to prepare size
controlled silver nanoparticles in the lab. Size controlled silver nanoparticles can be
conjugated with graphene quantum dots in the future. The AgNPs/GQDs method is
extremely sensitive to glucose and can be colorimetrically quantifed. The AgNPs/GQDs
sensor also has the potential to be used as a point of care diagnostic tool. As mentioned in
chapter 2, care needs to be taken to test the saliva samples from patients in a clinical
setting within two hours of a meal. It ensures that the correlation between blood glucose
testing and salivary glucose testing is preserved.
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.1. Graph showing the peak absorption and transmission intensities of different
H2 O2 concentrations detected using Nitroboronic Acid method
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.2. Graph showing the peak absorption and transmission intensities of different
H2 O2 concentrations using AgNPs in water
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(a) Absorption intensity at 8µM

(b) Absorption intensity at 25µM

(c) Absorption intensity at 50µM

(d) Absorption intensity at 100µM

(e) Absorption intensity at 220µM

Figure 4.3. Graph showing the peak absorption intensities of different H2 O2
concentrations using AgNPs in water
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.4. Absorption and Transmission curves of H2 O2 in Artifcial Saliva at fve
different concentrations
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(a) Absorption intensity at 8µM

(b) Absorption intensity at 25µM

(c) Absorption intensity at 50µM

(d) Absorption intensity at 100µM

(e) Absorption intensity at 220µM

Figure 4.5. Graph showing the peak absorption intensities of different H2 O2
concentrations using AgNPs in artifcial saliva
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(a) Absorption intensity at 8µM

(b) Absorption intensity at 25µM

(c) Absorption intensity at 50µM

(d) Absorption intensity at 100µM

(e) Absorption intensity at 220µM

Figure 4.6. Absorption intensities in water vs AS at 5 different H2 O2 concentrations
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.7. Results for indirect generation and sensing of H2 O2 at 220µM and 100µM
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.8. Absorption and transmission intensities of 100µM and 220µM glucose
concentrations with GOD at 5 min
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.9. Absorption and transmission intensities of 100µM and 220µM glucose
concentrations with GOD at 25 min
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.10. Absorption and transmission intensities of 100µM and 220µM glucose
concentrations with GOD at 60 min
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.11. Results of glucose and AgNPs and GOD solution in water experiment after 5
minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.12. Results of glucose and AgNPs and GOD solution in water experiment after
30 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.13. Results of glucose and AgNPs and GOD solution in water experiment after
60 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.14. Results of glucose and AgNPs + GOD experiment after 30 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.15. Results of glucose and AgNPs + GOD experiment after 60 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.16. Difference between peaks of 220µM and 8µM after 5 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.17. Difference between peaks of 220µM and 8µM after 30 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.18. Difference between peaks of 220µM and 8µM after 60 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.19. Replicates for 8 and 220µM at minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.20. Replicates for 8 and 220µM at 30 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.21. Replicates for 8 and 220µM at 60 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.22. Peak for 100µM in water after 5 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.23. Peak for 100µM in water after 30 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.24. Peak for 100µM in water after 60 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.25. Peak for 100µM in AS after 5 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.26. Peak for 100µM in AS after 30 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.27. Peak for 100µM in AS after 60 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.28. Peaks for 220µM and 8µM in AS after 5 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.29. Peaks for 220µM and 8µM in AS after 30 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.30. Peaks for 220µM and 8µM in AS after 60 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.31. Peaks for 220µM, 100µM and 8µM in AS after 5 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.32. Peaks for 220µM, 100µM and 8µM in AS after 30 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.33. Peaks for 220µM, 100µM and 8µM in AS after 60 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.34. Peaks for 220µM, 100µM and 8µM in fresh AS after 5 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.35. Peaks for 220µM, 100µM and 8µM in fresh AS after 30 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.36. Peaks for 220µM, 100µM and 8µM in fresh AS after 60 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.37. Peaks for 220µM, 100µM and 8µM in fresh AS after 5 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.38. Peaks for 220µM, 100µM and 8µM in fresh AS after 30 minutes
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(a) Absorption intensities

(b) Transmission intensities

Figure 4.39. Peaks for 220µM, 100µM and 8µM when tested exactly at 5 minutes
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Table 4.1. Prediction accuracies from selected models
Models
Prediction Accuracy (%)(Test data)
Medium Tree
100 (8/8)
Medium Gaussian SVM 75 (6/8)
Quadratic SVM
62.5 (5/8)
Cubic SVM
62.5 (5/8)
Bagged Trees
75 (6/8)

Table 4.2. Models NOT selected for future analysis
Models
Prediction Accuracy (%)(Test data)
Complex Tree
100 (8/8)
Simple Tree
100 (8/8)
Logistic Regression
62.5 (5/8)
Linear SVM
62.5 (5/8)
Fine Gaussian SVM
100 (8/8)
Coarse Gaussian SVM 50 (4/8)

Table 4.3. Results summary of experiments for detection of H2 O2 directly using AgNPs
method in water
S.No. Sample solution
Blank solution
Repl.
Results summary
visual
1
220µM , 100µM , Water (300µL) + AgNPs 1 for Clear
separability
every
50µM , 25µM , 8µM (700µL)
between
conc.
H2 O2 concentrations
concentrations.
in water (300µL) +
(Ref fgs 4.2(a),
AgNPs (700µL)
4.2(b))
2
220µM , 100µM , Water (300µL) + AgNPs 1 for Replication
50µM , 25µM , 8µM (700µL)
experiment.
every
H2 O2 concentrations
Results
are
conc.
repeatable. (Ref
in water (300µL) +
fgs 4.3)
AgNPs (700µL)
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Table 4.4. Results summary of experiments for detection of H2 O2 directly using AgNPs
method in Artifcial Saliva
S.No. Sample solution
Blank solution
Repl.
Results summary
signifcant
1
220µM , 100µM , Water (300µL) + AgNPs 1 for No
peaks
were
every
50µM , 25µM , 8µM (700µL)
observed. (Ref
conc.
H2 O2 conc.
in AS
fgs 4.4)
(300µL) + AgNPs
(700µL)
2
220µM , 100µM , Water (300µL) + AgNPs 1 for Replication
50µM , 25µM , 8µM (700µL)
experiment. No
every
H2 O2 conc.
signifcant peaks
conc.
in AS
were observed.
(300µL) + AgNPs
(Ref fgs ??)
(700µL)

Table 4.5.: Result summary of experiments for AGNPs using
indirect H2 O2 in water
S.No. Sample solution
1
Glucose conc. 220µM
and 100µM (700µL)+
GOD sol (300µL)+
AgNPs
in
water
(700µL)

Blank solution
Repl.
Water (700µL) + GOD 1
solution (300µL) +
AgNPs (700µL)

2

Water (700µL) + GOD
solution (700µL) +
AgNPs (700µL)

Glucose conc. (700µL)
+ GOD sol (700µL)
+ Ag NPs in water
(700µL)

1

Results summary
Peaks indicating
presence of H2 O2
are seen (ref fgs
4.7) Absorbency
at
220µM
and
100µM:
3.5% and 1%
respectively.
Peaks
are
observed
with
greater
absorption value
after 60mins (ref
fgs 4.8, 4.9 and
4.10) Absorbency
at 220µM and
100µM
after
60mins: 4% and
2% respectively.
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Table 4.5.: Result summary of experiments for AGNPs using
indirect H2O2 in water (continued)
S.No. Sample solution
3
Glucose
conc.
(1400µL) + GOD
sol (1400µL) + Ag NPs
in water (1400µL)

Blank solution
Repl.
Water (1400µL) + GOD 1
solution (1400µL) +
AgNPs (1400µL)

4

Glucose
(1400µL)
+ GOD in AgNPs
(1400µL)

Water
(1400µL)
+ 1
GOD solution in AgNPs
(1400µL)

5

220
µM
Glucose
(1400µL) + GOD in
AgNPs (1400µL)

Water
(1400µL)
+ 4
GOD solution in AgNPs
(1400µL)

Results summary
Bigger
peaks
when compared
to the above
two experiments
were
obtained
(ref fgs 4.11,
4.12 and 4.13)
Absorbency
at
220µM
and
100µM
after
60mins:
5% and 3.5%
respectively.
Positive results
were obtained.
Peaks
were
greater
than
the top three
experiments
(ref fgs 4.14 and
4.15) Absorbency
at
220µM
and
100µM
after
60mins:
6.5% and 5%
respectively.
Replicate
experiment.
Results
were
repeatable.
(ref fgs 4.16,
4.17 and 4.18)
Absorbency
at
220µM
after
60mins: 5.5%
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Table 4.5.: Result summary of experiments for AGNPs using
indirect H2O2 in water (continued)
S.No. Sample solution
6
8
µM
Glucose
(1400µL) + GOD
in AgNPs (1400µL)

Blank solution
Repl.
Water
(1400µL)
+ 4
GOD solution in AgNPs
(1400µL)

7

220 µM and 8µM
Glucose
(1400µL)
+ GOD in AgNPs
(1400µL)

Water
(1400µL)
+ 3, 3
GOD solution in AgNPs
(1400µL)

8

100
µM
Glucose
(1400µL) + GOD in
AgNPs (1400µL)

Water
(1400µL)
+ 4
GOD solution in AgNPs
(1400µL)

Results summary
Replicate
experiment.
Results
were
repeatable.
(ref fgs 4.16,
4.17 and 4.18)
Absorbency
at 8µM after
60mins: 1%
Replicate
experiment.
Results
were
repeatable.
(ref fgs 4.19,
4.20 and 4.21)
Absorbency
at
220µM and 8µM
after
60mins:
5%
and
1%
respectively.
100µM lied in
between 220µM
and 8µM which
proved the linear
detection in the
range 8 - 220
µM. (ref fgs
4.22, 4.23 and
4.24) Absorbency
at 100µM after
60mins: 3.5%
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Table 4.6.: Results summary of experiments for detection of
H2 O2 generated indirectly using AgNPs method in AS
S.No. Sample solution
Blank solution
1
100 µM Glucose in AS Water (1400µL) + Ag
(1400µL) + Ag NPs + NPs + GOD (1400µL)
GOD (1400µL)

Repl.
4

2

220µM and 8µM
Glucose
in
AS
(1400µL) + Ag NPs +
GOD (1400µL)

Water (1400µL) + Ag
NPs + GOD (1400µL)

4, 4

3

100µM Glucose in AS
(1400µL) + Ag NPs +
GOD (1400µL)

Water (1400µL) + Ag
NPs + GOD (1400µL)

4

Results summary
Peaks are greater
in AS than in
water at the
same
100µM
concentration
(ref fgs 4.25 and
4.26, 4.27)
Replication
experiment and
comparison with
100µM
AS
peaks.
220µM
and 8µM were
clearly separable
but
100µM
was higher than
220µM. (ref fgs
4.28, 4.29 and
4.30)
Replication
experiment.
100µM
still
higher
than
220µM.
The
impact
of
different blanks
was anticipated.
(ref fgs 4.31,
4.32 and 4.33)
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Table 4.6.: Results summary of experiments for detection of H2O2
generated indirectly using AgNPs method in AS (continued)
S.No. Sample solution
4
220µM, 100µM and,
8µM Glucose in AS
(1400µL) + Ag NPs +
GOD (1400µL)

Blank solution
Repl.
Water (1400µL) + Ag 3
NPs + GOD (1400µL)

5

Water (1400µL) + Ag
NPs + GOD (1400µL)

220µM, 100µM and,
8µM Glucose in AS
(1400µL) + Ag NPs +
GOD (1400µL)

3

Results summary
Replication
experiment. All
experiments
were conducted
with the same
blank.
100µM
was still higher
than
220µM.
Fresh vs Old AS
preparation effect
anticipated (ref
fgs 4.34, 4.35
and 4.36)
All
three
concentrations
prepared
and
used on the same
day with fresh
AS.
220µM
and 8µM are
separable
but
100µM has a
peak lower than
8µM. (ref fgs
4.37and
4.38)
Absorbency
at
220µM,
100µM,
8µM
after
30mins:
4.5%, 3.5%, 4%
respectively
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Table 4.6.: Results summary of experiments for detection of H2O2
generated indirectly using AgNPs method in AS (continued)
S.No. Sample solution
6
220µM, 100µM and,
8µM Glucose in AS
(1400µL) + Ag NPs +
GOD (1400µL)

Blank solution
Repl.
Water (1400µL) + Ag 3
NPs + GOD (1400µL)

Results summary
Fresh AS was
used.
All
measurements
are
taken
at
exactly
5
minutes. 220µM
and 8µM are
separable
but
100µM
has
a peak lower
than
8µM.
(ref fg 4.39)
Absorbency
at
220µM, 100µM,
8µM after 5mins:
6%, 3%, 4.5%
respectively

Table 4.7. Summary for the fndings for H2 O2 detection directly and indirectly using
silver nanoparticles method
Section
Result Summary
Method B1.1 - Detecting H2 O2 in Detection is possible and is shown
water using AgNPs
in results
Method B1.2 Detecting H2 O2 in Detection was not possible in this
artifcial saliva using AgNPs
research due to color fading into
colorless solution
Method B2.1- Detecting H2 O2 Detection is possible and is shown
generated from glucose and GOD in results
in water
Method B2.2 - Detecting H2 O2 No consistent pattern was found
More
generated from glucose and GOD in unlike method B2.1.
work is needed in order to make
artifcial saliva
conclusions.

Yes,
GOD

Yes,
GOD

Yes,
GOD

AgNPs coupled
with
graphene
quantum dots

AgNPs coupled
with
graphene
quantum dots

Gold
nanostar
silica
core
shell
particles
conjugated with
GOD

0.025 25

0.5 - 8

0.5.
10− 3 0.4

16

30

0.17

3

No

AuNPS coupled
with AgNPs

50.
10− 3
70.
−
10 3

EnzymeDetection LOD
basedrr Range
(µM)
(in mM)

Technique

Detects Actual Advantages of the
entire Samplesmethod
salivary Tested
glucose
range?
No
Human The need to use GOD
Serum is eliminated. Addition
of L-Cysteine improves
selectivity
toward
glucose remarkably.
Simple color fading is
Yes
N/R
Extremely
reported.
sensitive to the H2 O2
produced
Human Tested in the presence
No
Urine of fructose, galactose,
lactose and sucrose.
Sensor is selective to
glucose.
Human Tested in the presence
No
Saliva of uric acid and
ascorbic acid. Sensor is
selective to H2 O2

of

the

Reference

SERS
based (Al-Ogaidi
detection.Testing
et
al.,
was conducted on only 2014)
one saliva sample from
a volunteer

Tested
only
with (Chen et
aqueous sample. The al., 2014)
GQD/AgNPs hybrid is
stable up to 7 days
Needs a detection time (Nguyen
of 30 min at 400 C.
et
al.,
2018)

Needs a detection time (Gao et
of 40 min at 350 C.
al., 2017)

Disadvantage
method

Table 4.8.: Summary of other research related to alternate
glucose detection methods
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EnzymeDetection LOD
basedrr Range
(µM)
(in mM)

AgNP thin flm
glass substrate to
detect H2 O2

No
1 - 100
enzyme

1000

Ag@AuNPs
Yes,
2-6
330
modifed
GOD
graphene oxide
nanocomposite
Calix[4]arene
No
5.10− 6 0.0043
functionalized
enzyme boronic acid gold
100.10− 6
nanoprobe

Technique

No

No

Human No enzyme is used. Based
on
surface
Blood The molecular receptor plasmon
resonance.
selectively binds with Not suitable for PoC
diols. Reaction time of diagnostics.
2 minutes. Excellent
selectivity to D-glucose
in presence of other
sugars and proteins.
Human Fabricated glass flm Not tested on glucose
Urine sensor has stability for detection. Only tested
more than 6 weeks. on H2 O2 . Works only
Glass slides use very on patients with high
low amount of liquid oxidative stress.
for detection.

(Teerasong
et
al.,
2015)

(Pandya,
Sutariya,
&
Menon,
2013)

Detects Actual Advantages of the Disadvantage of the Reference
entire Samplesmethod
method
salivary Tested
glucose
range?
No
Human Sensor shows high SERS based detection. (Gupta et
Blood selectivity
in
the Not suitable to be PoC al., 2014)
presence of proteins

Table 4.8.: Summary of other research related to alternate
glucose detection methods (continued)
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CHAPTER 5. SUMMARY, CONCLUSIONS, AND
RECOMMENDATIONS
Detection and management of diabetes type II was presented in the current
research. A management method was presented by developing a prediction model that can
be used to predict the individual risk of diabetes based on risk factors. The model has been
validated on a small sized dataset (28 samples) but has the potential to work well with a
bigger dataset when one becomes available.
Detection of diabetes using artifcial saliva and water was c onducted. Glucose was
detected indirectly using the H2 O2 generated upon reaction of glucose with GOD .
Detection methods for direct and indirect detection of H2 O2 were presented. Results for
direct detection of H2 O2 were conducted to provide a proof of concept for glucose
detection using H2 O2 generated. These results show that H2 O2 could be detected in water
(absorbency of 11%, 7%, 5%, 3% and 1% were observed at 220µM, 100µM, 50µM,
25µM and 8µM respectively after a reaction time of 60 minutes) but not in artifcial saliva
(absorbency of 1 - 2% was observed for all concentrations of H2 O2 ). The results for
indirect H2 O2 detection show that glucose detection is possible in water in the range 8µM
- 220µM (absorbency of 6%, 3% and 1% were observed at 220µM, 100µM and 8µM
respectively after a reaction time of 60 minutes) . Glucose in artifcial saliva was not
detected linearly in the 8 - 220µM range (absorbency of 6%, 3% and 4.5% were observed
at 220µM, 100µM and 8µM respectively after a reaction time of 5 minutes). No specifc
pattern was found in the glucose detection results in artifcial saliva substrate.
The results indicate potential for future research to be conducted to detect glucose
in artifcial saliva c olorimetrically. Detecting H 2 O2 and glucose in water shows future
potential but does not have clinical signifcance as of n ow. Glucose in artifcial saliva has
the potential to be detected using size controlled AgNPs conjugated with graphene
quantum dots based on the review conducted in section 4.3.
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A recommendation To detect glucose in artifcial saliva, the following research
methodology is proposed. Size controlled silver nanoparticles are prepared in lab.
Graphene quantum dots will be prepared using the protocol by Chen et al. (2014). A
hybrid of AgNPs and GQDs will be created and used in place of the AgNPs solution used
in the current work. The glucose and GOD reaction will be used again but the
AgNPs/GQDs hybrid is postulated to increase sensitivity and selectivity of the proposed
biosensor towards D-glucose. The glucose detection will be quantifed using color change
by using a spectrophotometer.
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APPENDIX A. DATA MODELING

A.1 IRB protocol
The Purdue IRB requires the researchers to submit a form to determine if the
research involves human subjects or not. Based on the results of the determination, an IRB
review is required or exempted. For the current research, the form was submitted and IRB
provided an exempt. The related documents are attached below.

)URP
7R
'DWH
6XEMHFW

3XUGXH+533QRUHSO\#MRWIRUPFRP!
GHRU#SXUGXHHGX
30
3523(/'HWHUPLQDWLRQ1RW+XPDQ6XEMHFWV5HVHDUFK
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HUMAN RESEARCH PROTECTION PROGRAM
INSTITUTIONAL REVIEW BOARDS

7R6XUDQMDQ3DQLJUDKL
)URP3XUGXH8QLYHUVLW\+XPDQ5HVHDUFK3URWHFWLRQV3URJUDP +533
7LWOH&RPSXWDWLRQDOPRGHOWRSUHGLFWWKHLQFLGHQFHRI'LDEHWHVW\SH
'DWH
Re: PROPEL Determination-Not Human Subjects Research
Through the answers you provided in response to questions in the Purdue Research Online Portal Exemption Logic (PROPEL), Purdue’s HRPP has
determined that the research does not qualify as Human Subjects Research under federal human subjects research regulations (e.g., 45 CFR 46).
The answers provided in PROPEL indicate that you will NOT:
·

Collect data for the purpose of research intended to create generalizable knowledge. Reasons that are not considered research include
purposes such as internal programmatic evaluation, quality improvement, or business analysis.

·

Involve Human Subjects by collecting data from a living individual through intervention or interaction with the individual and/or identifiable
private information.

What are your responsibilities now, as you move forward?
·

If you have further questions about this determination, you must contact the Purdue IRB.

·

You and the members of your research team acknowledge that this study is subject to review at any time by Purdue’s HRPP staff, Institutional
Review Board, and/or Research Quality Assurance unit. At any time, this project may be subject to monitoring by these Purdue entities to
confirm the applicability of this determination. The Purdue IRB has final authority in determining if an activity is Human Subjects Research
requiring IRB review.

·

This determination is the Purdue HRPP assessment of regulations related only to human subjects research protections. This determination
does not constitute approval from any other Purdue campus department or outside agency. The Principal Investigator and all researchers are
required to affirm that the research meets all applicable local, state, and federal laws that may apply.

·

Finally, if any changes occur with respect to this project, recognize that such changes could change the need for review by HRPP/IRB. Should you
change the intent of the activity to involve publication, presentation, or any different application of this work, it is likely that IRB review will be
required. Therefore, it is important that you again complete PROPEL to ensure that the IRB review requirements remain the same.

Should you have any questions about your rights and responsibilities regarding conducting research with people, on this project or any other, please do
not hesitate to contact Purdue’s HRPP at irb@purdue.edu . We are here to help!
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A.2 Code used in SAS

A.2.1 Code used to make libraries permanent libraries

libname NH3C "W:\NHANES\Cont. NHANES\Data";
libname XPC xport "W:\NHANES\Cont. NHANES\Temp\ALQ_H.xpt";

proc copy in=XPC out=NH3C;
run;

A.2.2 Code used to keep variables
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libname NH3C "W:\NHANES\Cont. NHANES\Data";

data bodymeas_4yr;
set NH3C.bmx_g (keep = SEQN BMXBMI);
set NH3C.bmx_h (keep = SEQN BMXBMI);

data bp_4yr;
set NH3C.bpx_g (keep = SEQN BPXSY1
BPXSY2 BPXSY3 BPXSY4 BPXDI1 BPXDI2 BPXDI3 BPXDI4);
set NH3C.bpx_h (keep = SEQN BPXSY1
BPXSY2 BPXSY3 BPXSY4 BPXDI1 BPXDI2 BPXDI3 BPXDI4);

data lab_4yr;
set NH3C.ogtt_g (keep = SEQN LBDGLTSI);
set NH3C.ogtt_h (keep = SEQN LBDGLTSI);

data chol_4yr;
set NH3C.hdl_g (keep = SEQN LBDHDD);
set NH3C.hdl_h (keep = SEQN LBDHDD);

data diabetes_4yr;
set NH3C.diq_g (keep = SEQN DIQ170 DIQ175A DIQ175B DIQ175C
DIQ175D DIQ175E DIQ175F DIQ175G DIQ175H DIQ175I DIQ175J DIQ175K
DIQ175L DIQ175M DIQ175N DIQ175O DIQ175P DIQ175Q DIQ175R DIQ175S
DIQ175T DIQ175U DIQ175V DIQ175W DIQ050 DIQ060);
set NH3C.diq_h (keep = SEQN DIQ170 DIQ175A DIQ175B DIQ175C DIQ175D
DIQ175E DIQ175F DIQ175G DIQ175H DIQ175I DIQ175J
DIQ175K DIQ175L DIQ175M DIQ175N DIQ175O DIQ175P DIQ175Q
DIQ175R DIQ175S DIQ175T DIQ175U DIQ175V DIQ175W DIQ050 DIQ060);
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A.2.3 Code used to display contents

libname NH3C "W:\NHANES\Cont. NHANES\Data";

proc contents data = NH3C.rhq_e varnum;
proc contents data = NH3C.rhq_f varnum;
proc contents data = NH3C.rhq_g varnum;
proc contents data = NH3C.rhq_h varnum;
run;

A.3 Code used in MATLAB

1
2

%%Exported diabetes table and no diabetes reduced table before performing

3

%%PCA into the computer. These don't have the SEQN number in them

4

%%Also exported training and testing datasets after PCA into the computer

5

%%will create a new program with exported data

6
7
8

clc;

9

clear all;

10

%Reading Data into MATLAB

11

bodymeas = readtable('W:\NHANES\Cont. NHANES\Exported from SAS\bodymeas 5yr.txt');

12

bp = readtable('W:\NHANES\Cont. NHANES\Exported from SAS\bp 5yr.txt');

13

lab = readtable('W:\NHANES\Cont. NHANES\Exported from SAS\lab.txt');

14

cholesterol = readtable('W:\NHANES\Cont. NHANES\Exported from SAS\chol 5yr.txt');

15

diabetes = readtable('W:\NHANES\Cont. NHANES\Exported from SAS\diabetes.txt');

16

demographics = readtable('W:\NHANES\Cont. NHANES\...

17

Exported from SAS\demographics 5yr.txt');

18

phys activity = readtable('W:\NHANES\Cont. NHANES\Exported from SAS\phys activity.txt');

19

alcohol = readtable('W:\NHANES\Cont. NHANES\Exported from SAS\alcohol 4yr.txt');

20

dietary = readtable('W:\NHANES\Cont. NHANES\Exported from SAS\dietary.txt');

21

smoking = readtable('W:\NHANES\Cont. NHANES\Exported from SAS\smoking.txt');

22

medical = readtable('W:\NHANES\Cont. NHANES\Exported from SAS\medical.txt');

23
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24

%Data Preprocessing starts here -------------------------------------------

25

bodymeas = table2dataset(bodymeas);

26

bp = table2dataset(bp);

27

lab = table2dataset(lab);

28

cholesterol = table2dataset(cholesterol);

29

diabetes = table2dataset(diabetes);

30

demographics = table2dataset(demographics);

31

phys activity = table2dataset(phys activity);

32

alcohol = table2dataset(alcohol);

33

dietary = table2dataset(dietary);

34

smoking = table2dataset(smoking);

35

medical = table2dataset(medical);

36
37

%Combining data from different datasets using the key word SEQN

38

c = join(bodymeas, bp, 'key', 'SEQN', 'type', 'inner', 'MergeKeys', true);

39

c = join(c, lab, 'key', 'SEQN', 'type', 'inner', 'MergeKeys', true);

40

c = join(c, cholesterol, 'key', 'SEQN', 'type', 'inner', 'MergeKeys', true);

41

c = join(c, diabetes, 'key', 'SEQN', 'type', 'inner', 'MergeKeys', true);

42

c = join(c, demographics, 'key', 'SEQN', 'type', 'inner', 'MergeKeys', true);

43

c = join(c, phys activity, 'key', 'SEQN', 'type', 'inner', 'MergeKeys', true);

44

c = join(c, alcohol, 'key', 'SEQN', 'type', 'inner', 'MergeKeys', true);

45

c = join(c, dietary, 'key', 'SEQN', 'type', 'inner', 'MergeKeys', true);

46

c = join(c, smoking, 'key', 'SEQN', 'type', 'inner', 'MergeKeys', true);

47

c = join(c, medical, 'key', 'SEQN', 'type', 'inner', 'MergeKeys', true);

48

c = dataset2table(c);

49

%Changing the names of the variables for ease of understanding

50

c.Properties.VariableNames{'BPXSY1'} = 'Systolic 1';

51

c.Properties.VariableNames{'BPXDI1'} = 'Diastolic 1';

52

c.Properties.VariableNames{'BPXSY2'} = 'Systolic 2';

53

c.Properties.VariableNames{'BPXDI2'} = 'Diastolic 2';

54

c.Properties.VariableNames{'BPXSY3'} = 'Systolic 3';

55

c.Properties.VariableNames{'BPXDI3'} = 'Diastolic 3';

56

c.Properties.VariableNames{'BPXSY4'} = 'Systolic 4';

57

c.Properties.VariableNames{'BPXDI4'} = 'Diastolic 4';

58

c.Properties.VariableNames{'LBDGLTSI'} = 'OGTT';

59

c.Properties.VariableNames{'LBDHDD'} = 'Lab Chol';

60

c.Properties.VariableNames{'DIQ170'} = 'healthriskfordiabetes';

61

c.Properties.VariableNames{'DIQ175A'} = 'familyhistory';

62

c.Properties.VariableNames{'DIQ175B'} = 'Overweight risk';

63

c.Properties.VariableNames{'DIQ175C'} = 'Age risk';

64

c.Properties.VariableNames{'DIQ175D'} = 'Poor diet risk';

65

c.Properties.VariableNames{'DIQ175E'} = 'Race risk';

66

c.Properties.VariableNames{'DIQ175F'} = 'Overweightbaby risk';
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67

c.Properties.VariableNames{'DIQ175G'} = 'Nophysactivity risk';

68

c.Properties.VariableNames{'DIQ175H'} = 'High BP risk';

69

c.Properties.VariableNames{'DIQ175I'} = 'High sugar risk';

70

c.Properties.VariableNames{'DIQ175J'} = 'High chol risk';

71

c.Properties.VariableNames{'DIQ175K'} = 'hypoglycemic risk';

72

c.Properties.VariableNames{'DIQ175L'} = 'extremehunger risk';

73

c.Properties.VariableNames{'DIQ175M'} = 'numblimbs risk';

74

c.Properties.VariableNames{'DIQ175N'} = 'visionblur risk';

75

c.Properties.VariableNames{'DIQ175O'} = 'fatigue risk';

76

c.Properties.VariableNames{'DIQ175P'} = 'anyone risk';

77

c.Properties.VariableNames{'DIQ175Q'} = 'doctor risk';

78

c.Properties.VariableNames{'DIQ175R'} = 'other risk';

79

c.Properties.VariableNames{'DIQ175S'} = 'GDM risk';

80

c.Properties.VariableNames{'DIQ175T'} = 'frequrination risk';

81

c.Properties.VariableNames{'DIQ175U'} = 'Thirst risk';

82

c.Properties.VariableNames{'DIQ175V'} = 'oversugar risk';

83

c.Properties.VariableNames{'DIQ175W'} = 'medication risk';

84

c.Properties.VariableNames{'DIQ050'} = 'takinginsulinnow';

85

c.Properties.VariableNames{'DID060'} = 'takinginsulinsince';

86

c.Properties.VariableNames{'RIAGENDR'} = 'Gender';

87

c.Properties.VariableNames{'RIDAGEYR'} = 'Age';

88

c.Properties.VariableNames{'RIDRETH3'} = 'ethnicity';

89

c.Properties.VariableNames{'PAQ706'} = 'Days Active at least 60mins';

90

c.Properties.VariableNames{'PAQ610'} = 'Days Vig work';

91

c.Properties.VariableNames{'PAD615'} = 'Min Vig Work';

92

c.Properties.VariableNames{'PAQ625'} = 'Days moderate work';

93

c.Properties.VariableNames{'PAD630'} = 'Min moderate work';

94

c.Properties.VariableNames{'PAQ655'} = 'Days Vig rec act';

95

c.Properties.VariableNames{'PAD660'} = 'Min vig rec activity';

96

c.Properties.VariableNames{'PAQ670'} = 'Days mod rec act';

97

c.Properties.VariableNames{'PAD675'} = 'Min mod rec act';

98

c.Properties.VariableNames{'PAD680'} = 'sedentary minutes';

99

c.Properties.VariableNames{'ALQ130'} = 'perdaydrinks';

100

c.Properties.VariableNames{'ALQ101'} = 'tweleve drinks per year';

101

c.Properties.VariableNames{'ALQ110'} = 'tweleve drinks per lifetime';

102

c.Properties.VariableNames{'DRQSDIET'} = 'specialdiet';

103

c.Properties.VariableNames{'DRQSDT4'} = 'sugarfreediet';

104

c.Properties.VariableNames{'DRQSDT7'} = 'diabeticdiet';

105

c.Properties.VariableNames{'DR1TKCAL'} = 'energy';

106

c.Properties.VariableNames{'DR1TPROT'} = 'protein';

107

c.Properties.VariableNames{'DR1TCARB'} = 'carbs';

108

c.Properties.VariableNames{'DR1TSUGR'} = 'totalsugar';

109

c.Properties.VariableNames{'DR1TFIBE'} = 'deitfiber';
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c.Properties.VariableNames{'DR1TTFAT'} = 'totalfat';

111

c.Properties.VariableNames{'DR1TSFAT'} = 'satfat';

112

c.Properties.VariableNames{'DR1TMFAT'} = 'monounsatfat';

113

c.Properties.VariableNames{'DR1TPFAT'} = 'poylunsatfat';

114

c.Properties.VariableNames{'DR1TCHOL'} = 'cholest diet';

115

c.Properties.VariableNames{'SMD641'} = 'perlastmonthcigar';

116

c.Properties.VariableNames{'SMD650'} = 'perdaycig';

117

c.Properties.VariableNames{'SMD030'} = 'age started reg smoking';

118

c.Properties.VariableNames{'SMQ040'} = 'smoke now';

119

c.Properties.VariableNames{'SMQ621'} = 'cig entire life';

120

c.Properties.VariableNames{'MCQ300C'} = 'close relative had diabetes';

121

c.Properties.VariableNames{'MCQ365B'} = 'Doctor told exercise';

122

c.Properties.VariableNames{'MCQ370B'} = 'Are you increasing exercise';

123

c.Properties.VariableNames{'MCQ365A'} = 'Doctor told lose weight';

124

c.Properties.VariableNames{'MCQ365D'} = 'Doctor told reduce fat';

125

c.Properties.VariableNames{'MCQ370A'} = 'Are you controlling losing weight';

126

c.Properties.VariableNames{'MCQ370D'} = 'Are you reducing fat';

127
128
129
130
131

%Changing the 'Don't know' and 'Refused to answer' responses to represent

132

%missing data

133

%Also changing all the factors to match risk and no risk for diabetes

134

%Risk corresponds to 1 and no risk corresponds to 0

135

c.age started reg smoking(c.age started reg smoking == 777) = NaN;

136

c.age started reg smoking(c.age started reg smoking == 999) = NaN;

137

c.smoke now(c.smoke now == 7) = NaN;

138

c.smoke now(c.smoke now == 9) = NaN;

139

c.smoke now(c.smoke now == 3) = 0; %This tells us that they don't smoke now

140

c.perlastmonthcigar(c.perlastmonthcigar == 77) = NaN;

141

c.perlastmonthcigar(c.perlastmonthcigar == 99) = NaN;

142

c.perdaycig(c.perdaycig == 777) = NaN;

143

c.perdaycig(c.perdaycig == 999) = NaN;

144

c.cig entire life(c.cig entire life == 77) = NaN;

145

c.cig entire life(c.cig entire life == 99) = NaN;

146

c.healthriskfordiabetes(c.healthriskfordiabetes == 2) = 0;

147

c.healthriskfordiabetes(c.healthriskfordiabetes == 7) = NaN;

148

c.healthriskfordiabetes(c.healthriskfordiabetes == 9) = NaN;

149

c.Days Vig work(c.Days Vig work == 77) = NaN;

150

c.Days Vig work(c.Days Vig work == 99) = NaN;

151

c.Min Vig Work(c.Min Vig Work == 7777) = NaN;

152

c.Min Vig Work(c.Min Vig Work == 9999) = NaN;
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153

c.Days moderate work(c.Days moderate work == 77) = NaN;

154

c.Days moderate work(c.Days moderate work == 99) = NaN;

155

c.Min moderate work(c.Min moderate work == 7777) = NaN;

156

c.Min moderate work(c.Min moderate work == 9999) = NaN;

157

c.Days Vig rec act(c.Days Vig rec act == 77) = NaN;

158

c.Days Vig rec act(c.Days Vig rec act == 99) = NaN;

159

c.Min vig rec activity(c.Min vig rec activity == 7777) = NaN;

160

c.Min vig rec activity(c.Min vig rec activity == 9999) = NaN;

161

c.Days mod rec act(c.Days mod rec act == 77) = NaN;

162

c.Days mod rec act(c.Days mod rec act == 99) = NaN;

163

c.Min mod rec act(c.Min mod rec act == 7777) = NaN;

164

c.Min mod rec act(c.Min mod rec act == 9999) = NaN;

165

c.perdaydrinks(c.perdaydrinks == 777) = NaN;

166

c.perdaydrinks(c.perdaydrinks == 999) = NaN;

167

c.tweleve drinks per year(c.tweleve drinks per year == 7) = NaN;

168

c.tweleve drinks per year(c.tweleve drinks per year == 9) = NaN;

169

c.tweleve drinks per year(c.tweleve drinks per year == 2) = 0;

170

c.tweleve drinks per lifetime(c.tweleve drinks per lifetime == 7) = NaN;

171

c.tweleve drinks per lifetime(c.tweleve drinks per lifetime == 9) = NaN;

172

c.tweleve drinks per lifetime(c.tweleve drinks per lifetime == 2) = 0;

173

c.close relative had diabetes(c.close relative had diabetes == 9) = NaN;

174

c.close relative had diabetes(c.close relative had diabetes == 7) = NaN;

175

c.Doctor told exercise(c.Doctor told exercise == 7) = NaN;

176

c.Doctor told exercise(c.Doctor told exercise == 9) = NaN;

177

c.Are you increasing exercise(c.Are you increasing exercise == 7) = NaN;

178

c.Are you increasing exercise(c.Are you increasing exercise == 9) = NaN;

179
180
181

%Dividing ethnicity into two classes

182

%Based on previous research, any race which is not white has a higher

183

%chance for diabetes

184

c.ethnicity(c.ethnicity

185

c.ethnicity(c.ethnicity == 3) = 0;%White

6=

3) = 1;%Non- White

186
187

%Setting cut offs for lab cholestrol values

188

%referenced from NIH Medline plus

189

%HDL

190

%< 40 for men is bad and < 50 for women is bad

191

%Creating a new lab chol column

192

new lab chol = zeros(size(c,1),1);

≥40

is acceptable for men.

≥50

is acceptable

193

new lab chol = array2table(new lab chol);

194

c = [c new lab chol];

195
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196
197

for i= 1:size(c,1)

198

if(c.Gender(i) == 1)

199

if(c.Lab Chol(i)

≥

40)

c.new lab chol(i) = 0;

200

elseif ((c.Lab Chol(i) < 40))

201

c.new lab chol(i) = 1;

202

end

203

end

204
205
206

if(c.Gender(i) == 2)
if(c.Lab Chol(i)

207

50)

c.new lab chol(i) = 0;

208

elseif ((c.Lab Chol(i) < 50))

209

c.new lab chol(i) = 1;

210

end

211
212

≥

end

213
214

% if(¬isnan(c.High chol risk(i)))

215

%

216

% end

217

end

c.new lab chol(i) = 1;

218
219

%Filling missing data in the systolic and diastolic columns from the

220

%dataset

221

%The original dataset has BP readings taken 4 times

222

%Here, I have written a loop to fill out missing data in the case of first

223

%set of missing BP readings

224
225
226
227
228

for i = 1:size(c,1)
if (isnan(c.Systolic 1(i)) && isnan(c.Diastolic 1(i)))
if (¬isnan(c.Systolic 2(i)) && ¬isnan(c.Diastolic 2(i)))
%making sure 2nd readings are not NAN and replacing

229

c.Systolic 1(i) = c.Systolic 2(i);

230

c.Diastolic 1(i) = c.Diastolic 2(i);

231
232
233
234
235
236
237
238

elseif (isnan(c.Systolic 2(i)) && isnan(c.Diastolic 2(i)))
%If second readings are also NAN
if (¬isnan(c.Systolic 3(i)) && ¬isnan(c.Diastolic 3(i)))
%Making sure 3rd anr not NAN and replacing
c.Systolic 1(i) = c.Systolic 3(i);
c.Diastolic 1(i) = c.Diastolic 3(i);
elseif (isnan(c.Systolic 3(i)) && isnan(c.Diastolic 3(i)))
%If third readings are also NAN
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if (isnan(c.Systolic 4(i)) && isnan(c.Diastolic 4(i)))

239
240

%Making sure 4th anr not NAN and replacing

241

c.Systolic 1(i) = c.Systolic 4(i);

242

c.Diastolic 1(i) = c.Diastolic 4(i);
end

243
244

end

245

end

246

end

247
248

end

249
250

%Creating a new BP column

251

BP = zeros(size(c,1),1);

252

BP = array2table(BP);

253

c = [c BP];

254

c.BP(c.BP == 0) = NaN;

255
256

%Dividing Bp into only two categories

257

for i = 1: size(c,1)

258

if ((c.Systolic 1(i) > 120) | | (c.Diastolic 1(i) > 80))
c.BP(i) = 1;

259
260

elseif ((c.Systolic 1(i)

262

≤

120 ) | | (c.Diastolic 1(i)

≤

80))

c.BP(i) = 0;

261

end

263
264

end

265
266

%Combining all smoking data into 1 column

267

%This column will have data in the form of number of cigars smoked in the

268

%last one month

269

%if it has 0 as the data value, then it means the person does not smoke

270

%All missing values were deleted after populating this data column

271

for i = 1:size(c,1)
if (c.age started reg smoking(i)== 0 | | c.smoke now(i) == 0)

272
273

c.perlastmonthcigar(i) = 0;

274

c.perdaycig(i) = 0;
end

275
276

end

277
278

total smoking = zeros(size(c,1),1);

279

total smoking = array2table(total smoking);

280

c = [c total smoking];

281

c.total smoking(c.total smoking == 0) = NaN;
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282
283

%Smoking data

284

%Identifying individuals who have never smoked

285

for i = 1:size(c,1)

286

if (c.age started reg smoking(i) == 0 && c.smoke now(i) == 0 && ...

287

c.perlastmonthcigar(i) == 0 && c.perdaycig(i) == 0)
c.total smoking(i) = 0;

288
289

end

290
291

end

292

% Identifying individuals who smoked previously but quit now

293

for i = 1:size(c,1)
if ((c.age started reg smoking(i)

294
295

6=

0 &&

¬isnan(c.age started reg smoking(i))) && c.smoke now(i) == 0 ...

296

&& c.perlastmonthcigar(i) == 0 && c.perdaycig(i) ==0)

297

c.total smoking(i) = 0;
end

298
299

end

300

%To identify individuals who still smoke. Then,multiply days by no. of

301

%cigars to find out number of cigars smoked in a month

302

for i = 1:size(c,1)
if ( c.perlastmonthcigar(i)

303

6
=

0 && c.perdaycig(i)

0)

end

305
306

end

307

%Also identifying individuals who never smoked

308

for i = 1:size(c,1)
if (c.age started reg smoking(i) == 0)

309
310

6=

c.total smoking(i) = c.perlastmonthcigar(i)*c.perdaycig(i);

304

%Never smoked
c.total smoking(i) = 0;

311

end

312
313

if(c.cig entire life(i) == 1 | | c.cig entire life(i) == 2 | |

314
315

c.cig entire life(i) == 3 )
c.total smoking(i) = 0;

316

end

317
318
319

end

320
321

%For a classification learner to work, we will have to set cut off values

322

%for OGTT

323

%Reference for this: WHO diabetes program

324

%Link: http://www.who.int/diabetes/action online/basics/en/index2.html
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325

for i = 1:size(c,1)
if (c.OGTT(i) < 7.8 )

326

c.OGTT(i) = 0;

327
328

elseif (c.OGTT(i)

329

≥

7.8 &&

≥

11)

c.OGTT(i) < 11)

c.OGTT(i) = 1;

330
331

elseif (c.OGTT(i)

332

c.OGTT(i) = 2;

333
334

end

335
336

end

337
338
339
340
341
342

%As per ADA guidelines women can have

343

%≤ 2 drinks per day

344

%Creating a new column to document over all drinking habits

345

overall drinking = zeros(size(c,1),1);

≤

1 drink per day and men can have

346

overall drinking = array2table(overall drinking);

347

c = [c overall drinking];

348

c.overall drinking(c.overall drinking == 0) = NaN;

349
350
351

for i = 1: size(c,1)
if(c.Gender(i) == 1)
if(c.perdaydrinks(i) > 2)

352

c.overall drinking(i) = 1;

353

elseif (c.perdaydrinks(i)

354

end

356
357
358

end
if(c.Gender(i) == 2)
if(c.perdaydrinks(i) > 1)

359

c.overall drinking(i) = 1;

360

elseif (c.perdaydrinks(i)

361

≤

1)

c.overall drinking(i) = 0;

362

end

363
364

2)

≤

c.overall drinking(i) = 0;

355

end

365
366
367

if(c.tweleve drinks per year(i) == 0)
c.overall drinking(i) = 0;
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end

368
369

if(c.tweleve drinks per lifetime(i) == 0)

370

c.overall drinking(i) = 0;

371

end

372
373

end

374
375

%As per ADA recommendations, less than 7% of energy must be consumed from

376

%saturated fat, <1% of energy should be consumed from trans fat and <300 mg

377

%cholestrol per day

378

%Creating a new column to document overall dietary habits

379

Overall diet = zeros(size(c,1),1);

380

Overall diet = array2table(Overall diet);

381

c = [c Overall diet];

382

c.Overall diet(c.Overall diet == 0) = NaN;

383
384

for i = 1: size(c,1)

385
386

if(c.satfat(i)

≥

0.10 * c.energy(i) | | c.cholest diet(i)

(c.totalfat(i)

388

c.Overall diet(i) = 1;

≥

c.Overall diet(i) = 0;
end

393

if(c.Gender(i) == 1)
if (c.deitfiber (i)

395

≥

38)

c.Overall diet(i) = 0;

396

elseif (c.deitfiber (i) < 38)

397

c.Overall diet(i) = 1;

398

end

399
400
401

end

402
403

if(c.Gender(i) == 2)
if (c.deitfiber (i)

404

25)

elseif (c.deitfiber (i) < 25)

406

c.Overall diet(i) = 1;

407

end

408

410

≥

c.Overall diet(i) = 0;

405

409

0.65 *c.energy(i)))))

(c.totalfat(i) < 0.30 * c.energy(i)) && ((c.carbs(i) < 0.65 *c.energy(i))) )

391

394

≥

elseif(c.satfat(i) < 0.10 * c.energy(i) && c.cholest diet(i) < 300 && ...

390

392

300 | | ...

0.30 * c.energy(i)) | | (( (c.carbs(i)

387

389

≥

end
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411

if(c.Age(i)

18)

if((c.protein(i) < 0.1 * c.energy(i)) | | (c.protein(i) > 0.35 * c.energy(i)))

412

c.Overall diet(i) = 1;

413

elseif((c.protein(i)

414

≥

0.1 * c.energy(i)) && (c.protein(i)

≤

0.35 * c.energy(i)))

c.Overall diet(i) = 0;

415

end

416
417

≥

end

418
419

% if(c.Doctor told reduce fat(i) == 1 && c.Are you reducing fat(i) == 2)

420

%

421

% end

422

%

423

% if(¬isnan(c.Poor diet risk(i)))

424

%

425

% end

c.Overall diet(i) = 1;

c.Overall diet(i) = 1;

426
427

end

428
429

%Creating a single physical activity column

430

Physical fitness = zeros(size(c,1),1);

431

Physical fitness = array2table(Physical fitness);

432

c = [c Physical fitness];

433

idx = find(isnan(c.Days Vig work) & isnan(c.Days moderate work) & ...

434
435

isnan(c.Days Vig rec act) & isnan(c.Days mod rec act) &
isnan(c.Days Active at least 60mins) & isnan(c.Nophysactivity risk));

436

%Changing all the rows which have NaNs in Days Vig work and

437

%Days moderate work and Days Vig rec act and Days mod rec act to 999s

438
439

%Changing all NaNs in physical fitness to 999s for the sake of logical

440

%computation

441

c.Physical fitness(idx) = 999;

442

c.Days Vig work(isnan(c.Days Vig work)) = 0;

443

c.Min Vig Work(isnan(c.Min Vig Work)) = 0;

444

c.Days moderate work(isnan(c.Days moderate work)) = 0;

445

c.Min moderate work(isnan(c.Min moderate work)) = 0;

446

c.Days Vig rec act(isnan(c.Days Vig rec act)) = 0;

447

c.Min vig rec activity(isnan(c.Min vig rec activity)) = 0;

448

c.Days mod rec act(isnan(c.Days mod rec act)) = 0;

449

c.Min mod rec act(isnan(c.Min mod rec act)) = 0;

450

%Changing back all the 999s to NaNs for clarity in code

451

c.Physical fitness(c.Physical fitness == 999) = NaN;

452
453
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454

%Populating the overall physical activity column

455

for i = 1:size(c,1)

456

if(¬isnan(c.Physical fitness(i)))
c.Physical fitness(i) = (2 * c.Days Vig work(i)

457
458

* c.Min Vig Work(i)) + ...
(c.Days moderate work(i) * c.Min moderate work(i)) + (2*

459
460

c.Days Vig rec act(i) * c.Min vig rec activity(i)) + ...
(c.Days mod rec act(i) * c.Min mod rec act(i));

461
462

end

463
464

end

465
466

%According to ADA,

467

%have < 150 mins /week of exercise, their chances of diabetes type 2 are

468

%very high

469

overall fitness = zeros(size(c,1),1);

470

overall fitness = array2table(overall fitness);

471

c = [c overall fitness];

472

c.overall fitness(c.overall fitness == 0) = NaN;

473

for i = 1: size(c,1)

≥

150 mins per week of exercise is required. If people

if(c.Physical fitness(i)

474

≥

150)

c.overall fitness(i) = 0;

475
476

end

477

if(c.Physical fitness(i) < 150)
c.overall fitness(i) = 1;

478

end

479
480
481

%

if(¬isnan(c.Nophysactivity risk(i)))

482

%

483

%physical fitness or less physical fitness

484

%

485

%

c.overall fitness(i) = 1;

end

if(c.Doctor told exercise(i) == 1 && c.Are you increasing exercise(i) == 2)

486

c.overall fitness(i) = 1;

487

end

488
489

%Which shows that they have no

end

490
491
492
493

%According to USDA maximum calorie consumption is 3200

494

%calories for men and 2400 for women.

495

%Creating a new column to document overall calorie consumption

496

high calorie consumption = zeros(size(c,1),1);
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497

high calorie consumption = array2table(high calorie consumption);

498

c = [c high calorie consumption];

499

c.high calorie consumption(c.high calorie consumption == 0) = NaN;

500

for i = 1: size(c,1)
if (c.Gender(i) == 1)

501

if(c.energy(i) > 3200)

502

c.high calorie consumption(i) = 1;

503

elseif(c.energy(i)

504

≤

3200)

c.high calorie consumption(i) = 0;

505

end

506

end

507
508

if (c.Gender(i) == 2)

509

if(c.energy(i) > 2400)

510

c.high calorie consumption(i) = 1;

511

elseif(c.energy(i)

512

≤

2400)

c.high calorie consumption(i) = 0;

513

end

514

end

515
516
517

end

518

% deleting all the NaNs in Overall diet columns

519

idx = find(isnan(c.Overall diet));

520

c(idx,:) = [];

521
522

% %Deleting all NaNs from drinking

523

idx = find(isnan(c.overall drinking));

524

c(idx,:) = [];

525
526

%%For now, deleting all the prediabetic cases

527

idx = find(c.OGTT == 1);

528

c(idx,:) = [];

529
530

%Deleting all NaNs from total smoking

531

idx = find(isnan(c.total smoking));

532

c(idx,:) = [];

533
534

% %Deleting all the rows that have NaNs in OGTT

535

idx = find(isnan(c.OGTT));

536

c(idx,:) = [];

537

% %Deleting all the rows that have NaNs in BMI

538

idx = find(isnan(c.BMXBMI));c(idx,:) = [];

539
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540

%Deleting all NaNs from BP measurement

541

idx = find(isnan(c.BP));

542

c(idx,:) = [];

543
544

%Deleting all NaNs from overall fitness

545

idx = find(isnan(c.overall fitness));

546

c(idx,:) = [];

547
548

%In the original NHANES documentation diabetes is represented by 2

549

%Changing all diabetic cases to 1 just for clear understanding

550

%Now, the output classes are 0 and 1

551

% 0 indicates no diabetes and 1 indicates diabetes

552

c.OGTT(c.OGTT == 2) = 1;

553
554

X = c(:,[1:2,11,39,40,42,82:86,88:89]);

555

%dataset with variables we need for

556

%%Normalizing the data (This includes bringing the mean to 0 and scaling

557

%%it)

558

%Starting from the second column because the first column is SEQN

559

for i = 2: size(X,2)

560

min value = min(X{:,i});

561

max value = max(X{:,i});

modeling

562

for j = 1:size(X,1)

563

X{j,i} = ((X{j,i} - min value)/(max value - min value));

564

end

565
566

end

567
568

%Sorting the data

569

%Sorting the table join data based on 0s and 1s in OGTT column

570

X = sortrows(X,3);

571
572

%Checking for the number of NaNs now

573

temp = X;

574

temp = table2dataset(temp);

575

temp = double(temp);

576

check nan = isnan(temp(:,:));

577

count(1:size(temp,2)) = 0;

578

%Each column in this check nan will show how many NaNs that column has

579

for i = 1 : size(count,2)

580
581
582

for j = 1:size(temp,1)
if check nan(j,i) == 1
count(i) = count(i) + 1;
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end

583

end

584
585

end

586
587
588

mat X = table2array(X(:,2:end));

589
590

%Storing all datasamples with no diabtes

591

No diabetes = mat X(1:sum(mat X(:,2) == 0),:);

592

%Storing all data samples with diabetes

593

diabetes table = mat X(size(No diabetes,1)+1:end,:);

594

%This is to deal with class imbalance

595

%Deleting instances from the over represented class. It is called "under

596

%sampling"

597

No diabetes reduced = datasample(No diabetes,size(diabetes table,1));

598
599
600

mat input to PCA = [No diabetes reduced ; diabetes table];

601

Y = mat input to PCA(:,2);

602

mat input to PCA(:,2) = [];

603

[coeff,score,latent,tsquared,explained,mu] = pca(mat input to PCA);

604

%using the cumulative variance. Using components which can explain 95%

605

%variance of the model

606

total = 0;

607

for i= 1 :size(explained,1)

608

if (total

≥95)

break;

609
610

end

611

if (total < 95)
total = sum(explained(1:i,1));

612
613

end

614

end

615
616

Number PCA = i-1;

617

B = cumsum(explained);

618

hold on

619

plot(B,'r')

620

plot(explained)

621

legend('cumulative variance','individual variances')

622

hold off

623

input matrix full = [score(:,1:Number PCA) , Y];

624

temp = sum(input matrix full(:,Number PCA + 1) == 0)

625
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626

No diabetes after PCA = input matrix full(1:temp,:);

627

diabetes after PCA = input matrix full(temp+1:end,:);

628
629

%Dividing the sample into 70:30 - training:testing

630

%ratio for diabetic and

631

%non diabetic cases individually

632

%This is for non-diabetic cases

633

Q = size(No diabetes reduced,1);

634

valRatio = 0;

635

trainRatio = 0.70;

636

testRatio = 0.30;

637

[trainInd,valInd,testInd] = dividerand(Q,trainRatio,valRatio,testRatio);

638

train no diabetes = No diabetes after PCA(trainInd,:);

639

test no diabetes = No diabetes after PCA(testInd,:);

640

%This is for diabetic cases

641

Q = size(diabetes table,1);

642

valRatio = 0;

643

trainRatio = 0.70;

644

testRatio = 0.30;

645

[trainInd,valInd,testInd] = dividerand(Q,trainRatio,valRatio,testRatio);

646

train diabetes = diabetes after PCA(trainInd,:);

647

test diabetes = diabetes after PCA(testInd,:);

648

%Combining nondiabetic and diabetic samples to form total training and

649

%testing samples

650

training = [train diabetes; train no diabetes];

651

testing = [test diabetes; test no diabetes];

652

%Testing the trained model using the test dataset

653

test = testing(:,1:end-1);

654

yfit = trainedModel.predictFcn(test);

655

%Comparing the predictions and test labels to get testing set accuracy

656

yfit(:,2) = testing(:,end);

657
658

correct predictions = sum(yfit(:,1)== yfit(:,2));

659

percentage = correct predictions/size(testing,1)

1

%These are before PCA. These have the output variable too. Output is the

2

clc;

3

clear all;

4

%second column of both the tables diabetes and no diabetes

5

diabetes table = load('diabetes table exported.mat');

6

no diabetes table = load('no diabetes exported.mat');

7

diabetes table = diabetes table.diabetes table;

8

no diabetes table = no diabetes table.No diabetes reduced;
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9

%%------------------------------------------------------------------------

10

%%This block of code is simply to verify the number of PCs if need be

11

%%

12

mat input to PCA = [no diabetes table ; diabetes table];

13

Y = mat input to PCA(:,2);

14

mat input to PCA(:,2) = [];

15

[coeff,score,latent,tsquared,explained,mu] = pca(mat input to PCA);

16

%using the cumulative variance. Using components which can explain 95%

17

%variance of the model

18

total = 0;

19

for i= 1 :size(explained,1)

20

if (total

≥95)

break;

21
22

end

23

if (total < 95)
total = sum(explained(1:i,1));

24
25

end

26

end

27
28

Number PCA = i-1;

29

plot(explained)

30

%%

31

%These are after PCA

32

%This is the result that gave PCA factors of 7 for 95% variance

33

testing = load('testing exported.mat');

34

training = load('training exported.mat');

35
36

testing = testing.testing;

37

training = training.training;

38
39

test = testing(:,1:7);

40

yfit = trainedModel23.predictFcn(test);

41

%Comparing the predictions and test labels to get testing set accuracy

42

yfit(:,2) = testing(:,8);

43

correct predictions = sum(yfit(:,1)== yfit(:,2));

44

percentage = correct predictions/size(testing,1)

